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1. Abstract 
 
 
Monitoring cellular calcium levels by fluorescent probes has become an important method 
to visualize cellular signaling processes. The development of genetically encoded calcium 
indicators (GECIs) strongly contributed to the application of calcium imaging which in 
contrast to synthetic calcium dyes enables cell-type specific labeling, long-term expression 
and therefore chronic imaging approaches. Whilst GECI engineering and optimization 
mainly focused on improving signal strength or calcium affinities and kinetics, little is 
known about the magnitude of interference of GECIs affecting cellular calcium homeostasis 
in host organisms. Various previous attempts to genetically express GECIs using calmodulin-
based indicators frequently resulted in pathological changes or decreased function of the 
GECI in the host organism. In contrast to calmodulin-based GECIs, calcium imaging studies 
in the nervous system of flies and mice expressing troponin C-based GECIs did not display 
detrimental changes. 
In this work, TN-XXL performance was confirmed by transgenic TN-XXL expression in a 
Thy1.2 driven mouse line which enabled chronic in vivo calcium imaging of sensory evoked 
calcium transients of layer 2/3 neurons of the visual cortex during monocular deprivation 
over weeks. In addition, a detailed analysis focused on TN-XXL expression, function, viability 
and biocompatibility in mice ubiquitously expressing TN-XXL under the β-actin promoter. 
TN-XXL expression was determined in almost all tissues examined and functionality was 
validated in a variety of cultured cell-types. In addition the applicability of ratiometric 
indicators for calcium imaging of dynamic and complex tissues was evaluated via the use of 
explants from developing and adult cardiac tissues. Moreover, the tolerance of long-term 
expressed TN-XXL was verified on cellular level and along with a genome wide 
transcriptional analysis and behavioral experiments TN-XXL biocompatibility was 
investigated with only minor effects on the host genome and behavior. 
Together this study not only establishes the first detailed combined observation of function 
and biocompatibility of a GECI ubiquitously expressed in a mouse model but also has set the 
foundation criteria necessary for the evaluation of transgenic mouse lines expressing GECIs. 
Transgenic TN-XXL expression in this β-actin mouse line further offers ease of use for 
calcium signaling studies in a variety of cell-types and tissues of pharmaceutical relevance. 
Moreover, the facilitated cell line production and the possibility to establish mouse line 
crossings with existing disease models can open new grounds for investigations of calcium 
related diseases in vitro and in vivo. 
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2. Introduction 
 
Fluorescence microscopy has become an integral part in the field of life science in the last 
decades. The success of fluorescence microscopy is based on the fundamental principle that 
the visualization of cells, cellular compartments or protein complexes within cells is 
achieved with a high contrast by fluorescent probe labeling. The detection of fluorescence 
with microscopes works with the following principle: an illuminating light beam excites 
fluorescent particles in a specimen which emit fluorescent light that further is collected by a 
photon detector (CCD camera, photo diode, etc.). To ensure a high contrast image the 
excitation and emission pathways are separated by optical filters. Further, the ability to 
visualize structures situated deep inside tissues with 2-photon microscopes or to resolve 
sub-diffraction patterns by super-resolution microscopy techniques such as STED, PALM 
and STORM strongly contributed to the success of fluorescence microscopy. 
Furthermore, fluorescence microscopy is not only of use for the visualization cells or 
cellular compartments but also enables the analysis, monitoring and manipulation of 
cellular processes by the application of fluorescent sensors, which are either synthetic or 
genetically encoded in origin. 
 
2.1 Fluorescence and Fluorescence Resonance Energy Transfer 
 
Fluorescence is defined as the characteristic of a molecule to emit photons upon absorption 
of light. The photoactive part is defined as a ‘fluorophore’ and consists mostly of aromatic 
rings that form a π-electron system. 
Fluorescence occurs in a fluorophore, when a photon elicited by an external light source 
excites an electron. This electron transits from a low energy ground state (S0) to a state of 
increased energy. Dependent of the energy level of the absorbed photon (hνEX) the electron 
can be elevated to different energy states (S1, S2,…) and subordinated vibrational levels (S1’). 
From this excited state ‘internal conversion’ occurs within femtoseconds causing a 
relaxation of the electron to the lowest energy level of the excited state (S1). When the 
electron falls back from S1 to its ground state S0 it emits energy in form of a photon (Figure 
1). This process takes place within nanoseconds and defines the fluorescent lifetime of a 
fluorescent probe. Due to the energy loss during internal conversion, the energy of the 
emitted photon (hνEM) is lower and therefore of longer wavelength than of the absorbed 
photon. 
INTRODUCTION 
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Figure 1: Jablonski diagram illustrating the cycle of fluorescence. An electron of a fluorophore is excited 
from the ground state (S0) to an excited state (S1’). Partially dissipating energy causes the drop to the 
singlet excited state (S1) within nanoseconds from where a photon is emitted and the electron returns to 
its ground state (S0). 
 
 
This wavelength difference (hνEX – hνEM) between excitation and emission is called ‘Stokes 
Shift’ which allows the use of fluorescence microscopy by the separation of the optical 
pathway for the excitation and emission channel. Due to the separation of excitation and 
emission channels a high image quality with high contrast and low background signal is 
achieved which benefits fluorescence microscopy in contrast to bright-field transmission 
microscope techniques. 
Fluorophores suitable for fluorescence microscopy need to possess a practical brightness 
which is defined by the extinction coefficient – the proportion of excitation light which is 
absorbed by a fluorophore – and the quantum efficiency. The quantum efficiency of a 
fluorophore is defined as the rate of the excitation light that is converted into fluorescence 
and is calculated from the ratio of emitted to absorbed photons. A higher quantum efficiency 
of a fluorophore implicates a low rate of non-radiative relaxation during the fluorescence 
process and therefore a reduced amount of light which is needed to excite the fluorophore. 
Hence, fluorophores which possess high quantum efficiency are more resistant to 
photobleaching. Long acquisition times and high light intensities in biological imaging can 
cause photobleaching, the irreversible chemical destruction of a fluorophore. Thus, the 
photostability or bleaching resistance is also an important characteristic for the use of 
fluorophores in fluorescence microscopy. As described above fluorescence is elicited by the 
emission of photon which is caused by the drop of an electron from excited singlet state (S1) 
to the ground state (S0). In some cases the excited electron can interconvert to an excited 
triplet state. In the triplet state electrons are trapped for microseconds to seconds and are 
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prone to incur chemical reactions with surrounding molecules (e.g. oxygen) which lead to 
photobleaching. Photobleaching is a cumulative effect of fluorophore loss from excitation-
emission cycles over time and strongly depends on the excitation intensity (Song et al., 
1995). 
But the effect of photobleaching is also volitional in fluorescence microscopy. 
Photobleaching can be used in fluorescence recovery after photobleaching (FRAP) 
experiments, an optical technique whereby excitation light of high energy irreversible 
destroys the fluorophores in a defined area of interest. Due to Brownian motion, intact 
fluorophores from the outside of the bleached area will diffuse and replace the destroyed 
probes. This method can be applied to investigate diffusion and membrane exchange rates 
in cells loaded with synthetic dyes or expressing fluorescent proteins (FPs) which are freely 
diffusible or tagged to membranes or other cellular compartments (Tripathi and Parnaik, 
2008; Houtsmuller, 2005; Axelrod et al., 1976). 
Apart from the irreversible destruction of a fluorophore by photobleaching, the fluorescence 
emission intensity of a fluorophore can also be reversibly decreased by quenching of the 
fluorophore. Quenching occurs by the interaction of fluorophores with ions changing the 
chemical environment or with other substances interfering with the fluorophore (collision 
quenching) (Eftink and Ghiron, 1981). 
Fluorescence resonance energy transfer (FRET) is a special form of quenching by which 
dipole-dipole interactions of fluorophores induce a non-radiative energy transmission from 
the donor to the acceptor fluorophore (Forster, 1946).  
 
 
 
 
Figure 2: The Principle of FRET. A schematic representation of FRET. The blue arrow indicates the donor 
excitation. The donor emission when no FRET is occurring and acceptor emission are depicted by the cyan 
and yellow arrow, respectively. 
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Whilst the excited donor transfers its energy to an acceptor fluorophore, the acceptor itself 
becomes excited and emits a photon. Bringing the donor and the acceptor in close proximity 
induces the interaction of donor and acceptor and leads to a decrease in the donor emission 
(quenching) and an increase in acceptor emission (Figure 2). In general the FRET efficiency 
is dependent on three parameters. Firstly, it is determined by the ‘spectral overlap integral’ 
which describes the overlap of the donor emission and the acceptor absorption spectrum. 
Secondly, the FRET efficiency is highly dependent on the intermolecular distance. The 
quantum mechanical energy transfer can only occur when donor and acceptor fluorophore 
come to close proximity. The distance by which the energy transfer efficiency is 50% is 
called ‘Förster distance’. Thirdly, the FRET efficiency is influenced by the orientation of 
dipole moments of donor and acceptor fluorophore to each other. An effect that can be 
neglected with small, freely rotating synthetic dyes but has to be taken into account with 
larger sized fluorescent proteins (~40 Å) being limited in their orientational distribution 
(Hink et al., 2003). 
Initially, FRET was used as a ‘spectroscopic ruler’ to measure distances between molecules 
tagged with fluorescent probes (Figure 2)(Stryer, 1978). Later the principle of FRET was 
extended to fluorescence microscopy whereby FRET enables ratiometric measurements of a 
fluorescent probe which emits light at two different wavelengths. The signal is calculated 
from the ratio of the two emission intensities. This ratiometric readout is more robust to 
misrepresentations of the investigated sample caused by motion artifacts, labeling 
differences and fluctuations of the illuminating light source or the recording device (CCD 
camera/PMT/Photo diode) than single fluorophore measurements (Helmchen, 2011). Due 
to these advantages FRET-based techniques are wide spread in fluorescence microscopy 
today and moreover build the basis for the development of FRET-based indicators that are 
applied in several cell biological disciplines, e.g. observing neuronal function by monitoring 
glutamate (Hires et al., 2008) and calcium levels (Mank et al., 2008) or by visualizing 
changes in neuronal membrane potentials (Dimitrov et al., 2007), and further to follow 
transcription in cells (Friedrich et al., 2010). 
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2.2. The Importance of Calcium Signaling 
 
Calcium ions impact nearly every phase of cellular life. As the most important second 
messenger, calcium is involved in secretion, contraction, cellular excitability, gene 
expression, cell proliferation and cell death (Berridge et al., 2000). In general, calcium acts 
in different forms on cellular processes. Signaling of calcium can either occur extracellularly 
through voltage gated calcium channels and receptor activated channels (e.g. ATP, 
acetylcholine, glutamate) or mediated intracellularly whereby calcium concentrations are 
controlled by the uptake and release from internal stores of cellular compartments (Figure 
3). 
A major part of calcium research has been focused on investigating signaling mechanisms 
underlying neuronal function in the central nervous system (CNS). In neurons of the 
nervous system calcium influx occurs as a consequence of electric current propagation over 
the plasma membrane during neuronal activity which triggers the activation of voltage 
gated calcium channels. Thereby calcium navigates neurotransmitter release from vesicles 
for signal propagation at the presynapse, gene regulation by activation of further 
downstream processes at the soma, and synaptic plasticity and memory consolidation at the 
postsynapse in spines (Limbäck-Stokin et al., 2004). Monitoring and understanding 
neuronal function became a key role in neuroscience and the direct coupling of the rise of 
internal calcium concentration with neuronal activity enabled researchers to monitor 
neuronal activity by measuring intracellular calcium concentrations visualized with 
synthetic or genetically encoded calcium sensors. 
However, calcium signaling is not only important for the maintenance of neuronal function 
in the brain through calcium influx from the extracellular space. Furthermore, most of the 
cellular signaling processes are regulated by alteration of intracellular calcium 
concentrations. Membrane receptors such as receptor tyrosine kinases or G-protein coupled 
receptors can be activated by numerous hormones which initiate a signaling cascade over 
activation of phospholipase C. Phospholipase C causes production of inositol-1,4,5-
triphosphat (IP3) which binds the IP3 receptor (IP3R) and triggers the release of calcium 
from the endoplasmic reticulum (ER). This leads to the activation of further downstream 
mechanisms, including metabolism, cell proliferation and gene regulation (Figure 3). 
Furthermore, in cardiac and skeletal muscle voltage gated calcium channels trigger the 
calcium-induced-calcium-release via calcium mediated activation of the ryanodine receptor 
(RYR) which initiates the calcium release from the sarcoplasmic reticulum (SR) and initiates 
the contraction process (Chueh and Gill, 1986; Lytton et al., 1992). 
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Figure 3: A schematic overview of cellular calcium signaling. Calcium mobilizing signals (blue) are 
stimulated through a variety of cell-surface receptors (R) including G-protein receptors (G) and receptor 
tyrosine kinases (RTK). These signals include: generation of Ins(1,4,5)P3 from phosphatidylinositol-4,5-
bisphosphate (PtdIns(4,5)P3) catalyzed by phosolipase C enzyms (PLCβ, PLCγ); cyclic ADP ribose (cADPR) 
and nicotinic dinucleotide phosphate (NAADP) generated from nicotinamide-adenine dinucleotide (NAD) 
and its phosphorylated derivative NADP by ADP ribosyl cyclase; sphingosine 1-phosphate (S1P) generated 
by a sphingosine kinase. The ON mechanisms (green) include calcium influx from voltage or ligand 
sensitive calcium channels or calcium release through internal channels: Ins(1,4,5)P3 receptors, ryanodine 
receptors (RYR), NAADP receptors and sphingolipid Ca2+ release-mediating protein of the ER (SCaMPER) 
which activate cell-type specific calcium sensitive processes (purple). And the OFF mechanisms (red) which 
pump calcium out of the cytoplasm over Na+/Ca2+ exchanger and plasma membrane Ca2+ ATPases 
(PMCA) to the extracellular space or via sarco-/endoplasmic reticulum Ca2+ ATPase (SERCA) back to ER/SR 
(TnC, troponin C; CAM, calmodulin; MLCK, myosin light chain kinase; CAMK, Ca2+/calmodulin dependent 
protein kinase; cAMP PDE, cyclic AMP phosphodiesterase; NOS, nitric oxdie synthase; PKC, protein kinase 
C; PYK2, proline-rich kinase 2; PTP, permeability transition pore). Adapted from (Berridge et al., 2000). 
 
 
These two systems are also able to co-operate e.g. in pancreatic cells where receptor 
activated calcium release from the ER is initialized by IP3R and RYR which regulate fluid and 
enzyme secretion (Cancela et al., 1999). 
High intracellular calcium levels occurring during calcium signaling would be cytotoxic 
when exposed over a long period of time and can elicit apoptotic mechanisms, therefore the 
internal calcium concentration is strictly regulated and excessive calcium is pumped out of 
the cell immediately, is retransferred to internal stores or buffered by calcium binding 
complexes which induce further signaling steps. The buffering of elevated intracellular 
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calcium can take place either via passive calcium buffers e.g. parvalbumin, calretinin 
shaping the amplitude and duration of calcium signals, or active calcium buffers e.g. 
troponin C (TnC) and calmodulin (CaM) that undergo conformational changes and activate 
further downstream processes. TnC mediates the interaction of actin and myosin during 
muscle contraction, whilst CaM is embedded in many general processes, including crosstalk 
between signaling pathways, ion channel modulation, metabolism and gene transcription. 
Furthermore, calcium signaling is not just restricted to single cells or cellular compartments, 
but can also manifest as information transmission in between cells and propagate over 
major parts of tissues in form of calcium waves. Intercellular calcium waves can either 
travel via gap junctions or by the activation of purinergic receptors via extracellular ATP 
(Osipchuk and Cahalan, 1992) and regulate a variety of processes e.g. trigger cilia movement 
to expel inhaled contaminants in lung epithelium (Lansley and Sanderson, 1999), coordinate 
the metabolic function in liver (Gaspers and Thomas, 2005), or modulate neuronal activity 
and information processing in the CNS when propagating over glial cells (Newman, 2001). 
Collapsing of the fine-tuning of calcium regulatory machinery due to exogenous 
environmental factors or mutations of genes involved in calcium regulation can implicate 
undesirable effects in the calcium homeostasis and impair calcium signaling. These calcium-
signaling abnormalities can have severe pathological consequences, e.g.  mutations of the 
RYR induced dysregulation of intracellular calcium release can cause neuromuscular 
disorders (Gommans et al., 2002; Treves et al., 2005), dysregulation of intracellular calcium 
transients during cardiac contraction can diminish force production and decrease cardiac 
function (Hasenfuss et al., 1992; Wehrens et al., 2005) and farther calcium dysregulations 
are also involved in neurodegenerative diseases, such as Alzheimer's or Parkinson disease 
(Wojda et al., 2008). 
The role of calcium as global player in regulating cellular functions and its function during 
the occurrence of diseases was a driving force for the investigations that have been 
performed to date. Furthermore, researchers began to develop tools to monitor calcium 
concentrations and to gain superior knowledge in the mechanisms of how calcium regulates 
physiological processes. The development of synthetic and genetically encoded fluorescent 
probes to trace calcium levels supported research for a better understanding of mechanisms 
that involve calcium fluctuations, such as memory consolidation and synaptic formation, but 
also brought new insights to neurodegenerative, cardiac and muscle diseases and cancer 
development (Berridge et al., 2003). 
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2.3. Synthetic Calcium Dyes 
 
Before the development of fluorescent probes that allow tracing of cellular calcium 
concentrations, researchers were constrained to electrophysiological recordings which are 
very complex regarding the equipment, time-consuming and recordings from a high number 
of cells at a time are difficult to achieve. The design and development of synthetic calcium 
dyes enabled non-invasive recordings of intracellular calcium signals solely with a 
fluorescence microscope and farther simultaneous monitoring of a high number of cells 
became possible. 
The first generation of synthetic calcium dyes emerged in the 1980’s. These versions were 
all hydrophilic, therefore not membrane-permeable and disadvantageous for non-invasive 
cell experiments. The breakthrough of synthetic calcium dyes for intracellular imaging 
began when Roger Tsien and colleagues developed fluorescent dyes fused to acetoxymethyl 
(AM) esters (Tsien, 1981). These AM-ester fused dyes are hydrophobic, can be bath-applied 
and are able to cross cell membranes and enter cells. Once infiltrated a cell the inactive 
esterified dyes become activated by de-esterification of endogenous esterases. The cleavage 
of the ester turns the dye hydrophilic, cell impermeable and therefore becomes trapped in 
the cell. Based on this principle numerous synthetic calcium dyes were developed with 
different calcium dissociation constants (Kd) for monitoring calcium signals of different 
concentrations. High affinity calcium dyes (e.g. Fura-2, OGB-1, Fluo-4) with low Kd values in 
the nano-molar range were developed to investigate systems with low calcium transients 
e.g. neuronal activity (Ohki et al., 2006; Stosiek et al., 2003), whereby affinity calcium dyes 
with high Kd values in micro molar range (e.g. Fluo-5N, OGB-5N) were constructed to 
observe calcium dynamics in models with high changes in calcium concentration e.g. in 
skeletal (DiFranco et al., 2002) and cardiac muscle (Fan and Palade, 1999). 
In general, synthetic calcium dyes are very successful in the field of calcium imaging due to 
the high brightness, bleach resistance, and fast kinetics. However, a major disadvantage of 
synthetic dyes is that cellular localization cannot be tightly controlled and targeting of 
particular cell types, subsets of cell or organelles is hardly achievable. The loading via 
membrane-permanent esters is often difficult or impossible in animals with thick cell walls 
or cuticles such as in the fruit fly Drosophila melanogaster or the nematode Ceanorhabditis 
elegans. Additionally, synthetic calcium dyes tend to compartmentalize and are eventually 
extruded from the cell during long-term recordings and they diffuse out of cell over time 
which obstruct the establishment chronic imaging experiments (Palmer and Tsien, 2006). 
These drawbacks especially manifest in experiments with tissue explants or in vivo 
preparations. Researchers tried different approaches to overcome these drawbacks e.g. by 
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microinjection of synthetic dyes which limited the recording number to a single cell at a 
time (Svoboda et al., 1999), electroporation or by bulk loading of cell-populations 
(Nagayama et al., 2007; Stosiek et al., 2003). But regardless of improvements concerning 
dye delivery the labeling remained unspecific and temporary. 
With the discovery and utilization of the green fluorescent protein (GFP) and numerous 
color variants researchers could overcome these drawbacks by engineering GFP-based 
genetically encoded calcium indicators (GECIs), biosensors that exclusively consist of amino 
acids and can be synthetized by the host cell or organism for a facilitated use to investigate 
calcium signaling (McCombs and Palmer, 2008). 
 
2.4. GFP – the Basis to Develop Genetically Encoded Indicators 
 
The discovery of GFP in 1962 by Shimomura in the jellyfish Aequorea victoria (Shimomura 
et al., 1962) and subsequent steps in the 1990s of solving the genetic sequence (Prasher et 
al., 1992), the 3 dimensional structure (Cubitt et al., 1995; Ormö et al., 1996; Yang et al., 
1996) and the ability to express cDNA of GFP in bacteria or nematodes (Chalfie et al., 1994) 
paved the way for the success that GFP holds in research today.  
 
 
 
Figure 4: Scheme of the crystal structure of GFP. Side view of the β-barrel (yellow) and the centered 
fluorophore (Ser65-Tyr66-Gly67) stabilized by α-helices (purple). In the right picture some residues are 
removed to allow a better view of the fluorophore. Modified from PDB-entry 1GFL (Yang et al., 1996).  
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During that time researchers elaborated that the formation of the GFP fluorophore under 
aerobic conditions is accomplished by autocatalytic cyclization of the 3 amino acids Ser65–
Tyr66–Gly67 in protection of the surrounding β-barrel consisting of 11 beta sheets (Figure 
4)(Tsien, 1998). Rapidly, scientist began to exchange residues surrounding the fluorophore 
by rational design, random mutagenesis and DNA shuffling eager to improve the wild-type 
GFP (Cormack et al., 1996; Heim et al., 1994; Crameri et al., 1996). That gave rise to new 
variants with improved brightness, photostability and spectral properties.  
The original GFP, being derived from the cold water jellyfish Aequorea victoria exhibited 
poor folding properties at 37°C. The addition of the mutations F64L which optimized the 
folding properties of GFP at 37°C and S65T that shifted the original excitation peak of GFP 
from 395nm to 488nm yielded the brighter and more stable version of GFP named 
enhanced GFP (EGFP) (Cormack et al., 1996). On the basis of EGFP further mutations broad 
up a variety of spectral versions. Mutating the residue Y66W gave rise to the cyan 
fluorescent protein (CFP) with excitation and emission maxima at 432nm and 475nm, 
respectively (Cormack et al., 1996). The development of the yellow fluorescent protein 
(YFP) which exhibits maximal fluorescence upon excitation at 514 nm at an emission at 
527nm was due to mutations at the coordinating residues S65G and T203F (Wachter et al., 
1998). Further mutations of YFP generated Citrine, an improved version to diminish pH, 
chloride sensitivity and increased photostability and protein folding properties (Griesbeck 
et al., 2001). The good spectral overlap of CFP and YFP variants rendered them the most 
successful FRET pair for the deployment to FRET-based biosensors to date (Piston and 
Kremers, 2007). 
The rapid development of GFP variants and the discovery of new orange and red fluorescent 
proteins (FPs) deriving from different organisms extended the color spectrum of FPs 
(Shaner et al., 2004). To date researchers can choose from a wide spectrum of FPs with 
various properties regarding color, brightness, photostability, folding efficiency and pH 
dependency. Moreover, specific expression of FPs in the cytosol or fused to endogenous 
cellular proteins allowed studying morphology and cellular dynamics of specific cell types, 
cellular organelles or compartments. Furthermore, the development of fusion-constructs 
consisting of FPs and a regulatory subunit of a protein enabled the design of functional 
single- and dual-wavelength biosensors to monitor a large variety of cellular processes 
using fluorescence microscopy. 
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2.5. Genetically Encoded Calcium Indicators (GECIs) 
 
Solely composed of DNA, a variety of genetically encoded sensors can be engineered by 
deleting, inserting or manipulating parts of the DNA. Furthermore, the use of cellular 
targeting sequences, cell-type or tissue specific promoters, and transgenic technologies 
provides methods of non-invasively expressing indicators in tissue of living organisms with 
cellular and sub-cellular specificity (Caroni, 1997; Hara et al., 2004; Mitsui et al., 2007). 
The development of GECIs was profoundly inspired from the desire to study neuronal 
activity. The coupling of electrical signal propagation during neuronal information 
transmission with the influx of calcium through voltage gated channels motivated 
researchers to develop genetically encoded tools to investigate the complexity of neuronal 
function. The advantages GECIs imply in contrast to synthetic calcium dyes further 
supported their development (see section 2.3). 
In general, GECIs consist of a calcium binding domain which undergoes a conformational 
change upon binding of calcium ions and is either fused to a single or two fluorescent 
proteins which transform conformational changes into a fluorescence readout. In single FP 
sensors the calcium binding modulates the brightness of the FP by changing the degree of 
protonation of the fluorophore (Figure 5 A), whereas dual FP sensors work on the principle 
of FRET (see section 2.1) whereby the binding of calcium induces a decrease donor 
fluorescence emission and an increase the acceptor fluorescence (Figure 5 B). 
The development of single FP GECIs rose with the observation that FPs tolerate insertions of 
large fraction without abolishing the fluorescence (Baird et al., 1999). The insertion of the 
calcium binding domain calmodulin from Xenopus at the position Tyr145 of YFP and further 
improvements due to folding problems and pH sensitivity by exchanging YFP to Citrine lead 
to the single FP GECIs Camgaroos, low sensitivity sensors with Kd values of 5-7 µM (Figure 
6 A)(Baird et al., 1999; Griesbeck et al., 2001). However, Camgaroos suffered from low 
fluorescence at basal calcium levels and therefore were difficult to detect when expressed in 
mammalian cells. A further step towards improved single FP GECIs yielded in the 
development of the Pericams, sensors whereby calmodulin and its binding peptide M13 
were fused to the N- and C-terminal ending of a circular permuted variant of YFP (YFP 
cp145) (Nagai et al., 2001). The new N-/C-terminal ends were situated in closer proximity 
to the fluorophore in order to allow a higher interference and higher response range of the 
sensor to calcium binding. Indeed, Flash pericam exhibited higher calcium affinity with Kd 
values of 0.2 - 1.7 μM and an increase of intensity upon calcium binding of up to 8-fold. 
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Figure 5: A schematic model of the working principle of single FP and FRET-based GECIs. (A) A single FP 
sensor consisting of a circular permuted GFP and a calcium binding unit (CBU). Upon binding of calcium 
the CBU changes conformation and induces a change in the protonation state of the GFP which leads to a 
fluorescence increase. (B) A FRET-based calcium indicator consisting of a donor (CFP) and acceptor (YFP) 
fluorophore fused to a CBU. Calcium binding elicit a conformational change which brings the two FPs in 
closer proximity and FRET can occur. Modified from McCombs and Palmer, 2008. 
 
 
However, the low fluorescence at basal calcium levels made expression almost undetectable 
in cell culture. 
On the building principle of the Pericams, a new class of single FP GECIs, the G-CaMPs, 
revolutionized the field of single FP calcium indicators. In G-CaMPs the fluorescence 
backbone of YFP was exchanged by a circular permuted variant of EGFP (EGFP cp149) and 
the amino acid residues 145-148 were deleted (Nakai et al., 2001). The first version showed 
similar disadvantages as Camgaroos and Pericams: dim basal fluorescence, pH sensitivity 
and slow maturation at 37°C. However after incorporation of several mutations new 
variants showed better folding, increased basal fluorescence, higher signal change upon 
calcium binding and high calcium affinities with a Kd value up to 150 nM were created (Tian 
et al., 2009). 
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Figure 6: Schematic overview of the major groups of single- and dual wavelength GECIs. (A) Single-
wavelength indicators Camgaroos, Pericams and G-CaMPs. In Camgaroos the calcium binding Xenopus 
calmodulin (XCaM) is inserted in between YFP variants. The Pericams use circularly permuted EYFP flanked 
by an N-terminal M13 peptide and a C-terminal XCaM. G-CaMPs share the same building principle as 
Pericams but exchanged YFP with GFP. (B) Dual-wavelength GECIs Yellow Cameleons (YC), TN-L15 and TN-
XXL consist of either TnC or XCaM/M13 serving as calcium binding domain which is sandwiched between 
CFP and YFP/Citrine or circular permuted variants. Modified from Mank and Griesbeck, 2008. 
 
 
Besides the low fluorescence at basal calcium concentrations single FP sensors are prone to 
imaging artifacts due to the single channel readout. Motion artifacts elicited by out-of-focus 
movements, fluctuations of the excitation light source or uneven cellular expression can lead 
to misinterpretations of the imaging data and distort the experimental outcome. 
To overcome these disadvantages dual fluorophore indicators that function on the basis of 
FRET were developed. The dual-channel ratiometric readout of fluorescence in FRET 
sensors counteracts imaging artifacts yielding a more consistent imaging readout which 
plays to the use of FRET-based sensors in moving preparations and in vivo experiments (e.g. 
heartbeat, respiratory movements). Common FRET pairs incorporated in dual FP indicators 
are of variants of CFP (ECFP, mCerulean (Rizzo et al., 2004), mTurquoise (Goedhart et al., 
2010)) and YFP (EYFP, mVenus (Nagai et al., 2002), mCitrine (Griesbeck et al., 2001)) which 
until to date exhibit the most optimal spectral overlap and exceed the best dynamic range. 
In general, two versions of dual FP indicators have evolved. On the one hand, the Cameleons, 
FRET-indicators of which calmodulin/M13 serves as the calcium binding unit that was 
already used in single FP indicators on the other hand GECI that incorporate troponin C 
(TnC) as calcium binding moiety (Figure 6 B). In vitro experiments with Cameleons show 
ratio changes up to 600 % and also high calcium affinity with Kd values of 50 – 250 nM. 
However, exposing calmodulin-based GECIs to in vivo conditions most of them exhibited 
poor performance, most likely a consequence of the interaction of calmodulin with the 
cellular machinery (Nagai et al., 2004). 
Therefore, FRET-based indicators with troponin C serving as calcium binding domain were 
developed in the research group of Oliver Griesbeck. TnC in contrast to calmodulin is not 
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endogenously expressed globally in every cell, but expression is restricted to skeletal and 
cardiac muscle whereby TnC incorporated in the troponin complex consisting of troponin C, 
I and T, is responsible for calcium binding during muscle contraction. The first TnC-based 
indicator incorporated a truncated variant of chicken skeletal TnC sandwiched between CFP 
and Citrine. This indicator, named TN-L15, was successfully expressed in mammalian cells 
and in transgenic animals where it reliably reported cytosolic calcium changes (Heim and 
Griesbeck, 2004; Heim et al., 2007). In terms of monitoring small calcium fluctuations which 
occur during neuronal firing the signal strength and sensitivity to magnesium ions 
diminished the dynamic range of TN-L15. A first attempt to reduce the magnesium 
sensitivity by mutating the residues N109D, D111N, N145D and D147N of the C-lobe of TnC 
gave rise to TN-XL, a high speed but low affinity sensor which turned out to be suitable for 
systems with high calcium fluctuations but inapplicable to monitor low changes in calcium 
concentration, e.g. single action potentials (Mank et al., 2006). A second step to increase 
calcium affinity by keeping low magnesium sensitivity was achieved by rearranging the TnC 
domain. 
 
 
 
Figure 7: Generation and in vitro properties of TN-XXL. (A) Schematic illustration of the rearrangement 
and substitution of N- and C-terminal domains of TN-XXL. Blue and yellow lines depict the fusion to CFP 
and cpCitrine, respectively. (B) Calcium affinity titration of TN-L15, TN-XL and TN-XXL. Modified from Mank 
et al, 2008. 
 
 
The low-affine N-terminal lobe of TnC (EF-Hand I and II) was replaced by the high affine C-
terminal lobe (EF-hand III and IV) resulting in a TnC chimera consisting of two C-terminal 
lobes (Figure 7 A). Furthermore, two mutations (N145D and D147N) were reversed in each 
of the C-terminal lobes. This yielded in the upgraded FRET-based GECI TN-XXL which 
deployed ratio changes of up to 250 % in vitro and reported an improved calcium affinity 
with a Kd value in the range of 800 nM (Figure 7 B). TN-XXL was amongst the first FRET-
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based GECIs able to resolve single action potentials measured in hippocampal slice 
preparations. Furthermore, in vivo calcium imaging in flies and successful chronic in vivo 
imaging in orientation selective neurons the primary visual cortex of anesthetized mice 
proved the potential of TN-XXL (Mank et al., 2008). 
 
2.6. Advances of Calcium Imaging Techniques 
 
Early imaging experiments were restricted due to the lack of advanced optical and technical 
devises suitable for fluorescence imaging. Using wide-field fluorescence microscopy or 
single photon confocal microscopy limited imaging depth therefore the use of imaging 
approaches was narrowed down to cell culture experiments or studies in optical 
transparent organisms like C. elegans or the zebrafish larvae. Moreover, intact tissues 
produce light scattering effects that even with a powerful laser pulse of a laser scanning 
confocal microscope hindered imaging in regions lying deeper than 50 – 100 µm (Russell, 
2011). 
With the development of the 2-photon microscope by Winfried Denk and colleagues in the 
1990s this depth limit could be broken and functional calcium imaging up to several 
hundreds of micrometers was possible due to the shift in laser excitation to the infrared 
which is less prone to light scattering and allows deeper tissue penetration (Denk et al., 
1990). As a consequence of this breakthrough optical imaging and computing technologies 
advanced rapidly in the past decades and enabled the development of increasingly 
sophisticated imaging approaches from in vitro cell experiments to in vivo imaging in intact 
tissues, whole intact anesthetized or even awake animals. 
There are two major aspects why in vivo application of calcium indicators are mainly 
restricted to investigations of neuronal activity in the brain. On the one hand the realization 
to perform in vivo calcium imaging experiments was driven by the fact that the brain is 
surrounded by thick bone which allows fixation of the head and enabled decoupling from 
body motion artifacts produced by body movements, heart beat or the respiratory system. 
On the other hand, the lack of knowledge how neuronal function and signal transmission are 
computed in the CNS encouraged researchers to observe the mechanisms underlying 
neuronal function, in circuits, synaptic transmission and signal propagation. Therefore, 
techniques were developed which allowed 2-photon microscopy in anesthetized and head-
fixed animals and in addition to record calcium responses e.g. in barrel and visual cortex 
with synthetic dyes and GECIs (Stosiek et al., 2003; Mrsic-Flogel et al., 2007; Heim et al., 
2007; Mank et al., 2008; Wallace et al., 2008). Furthermore, the application of GECIs enabled 
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chronic calcium imaging experiment in cortical pyramidal neurons of over days and weeks 
(Mank et al., 2008). 
Ongoing improvements of technical equipment either by mounting head-fixed awake mice 
on a Styrofoam ball (Dombeck et al., 2007) or by the installation of a miniature 2-photon 
microscope on the head of a freely moving rats (Helmchen et al., 2001) extended the 
diversity of imaging applications from anesthetized head-fixed animals to awake, freely 
moving and behaving animals. However, the mentioned 2-photon calcium imaging 
approaches still suffer from depth restrictions of 200-400 µm depending on the optics and 
used laser power which limit imaging to upper cortical layers and impair observations of 
deeper brain region. Improvements the of optical toolbox e.g. the development optical 
prisms for periscopic imaging (Murayama et al., 2007) or the invention of ultra-small, 
needle-like gradient index (GRIN) lenses for optical-fibers (Levene et al., 2004) allowed 
minimally invasive in vivo 2-photon calcium imaging on a subcellular resolution in depths 
up to several millimeters. A non-invasive way enabling the in vivo recording of calcium 
signal in deeper areas was the development of regenerative amplification multiphoton 
microscopy (RAMM). With this recently developed method spontaneous and sensory-
evoked neuronal calcium transients of layer 5 neurons located 800 µm deep in the cortex of 
anesthetized mice could be recorded in vivo (Mittmann et al., 2011). 
 
2.7. TN-XXL - a Suitable GECI for the Generation of Transgenic Mice 
 
The improvements in advanced microscopy techniques during the last decade would benefit 
from the generation of transgenic animals expressing a GECI since transfection, viral 
transduction or loading of the calcium indicator would become redundant. This would 
simplify the design and implementation of calcium imaging experiments. Furthermore, dye 
loading, transduction of calcium sensors by virus mediated gene transfer or electroporation 
need additional intervention and subsequently can cause stress for the animal that could 
distort the experimental outcome. With the generation of transgenic animals these aspects 
can be avoided. Likewise, the generation of transgenic animals needs a careful decision 
which promoter has to be selected. One has to take into account a promoter which provides 
expression in the preferred region of interest and at sufficient expression levels of the 
transgene to assure the applicability of the transgenic animal. 
Moreover, the most appropriate GECI in terms of brightness, dynamic range and cell 
viability has to be chosen. As mentioned above, in vivo imaging studies of calmodulin-based 
GECIs like G-CaMPs and Yellow Cameleons (YC) showed impairment of the GECI during 
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long-term expression. Additionally, it has been reported that in some cases the production 
of transgenic animals expressing calmodulin-based GECIs was accompanied by severe 
morphological defects, aggregation and loss of function of the indicator (Hasan et al., 2004; 
Tallini et al., 2006; Tian et al., 2009). The mentioned effects are thought to manifest due to 
the interaction of the indicators’ CaM with endogenous CaM and the interference with 
downstream signaling pathways. Furthermore, this hypothesis was supported by a study 
whereby overexpression of CaM in ventricular cardiomyocytes of mice perturbed DNA 
synthesis during the cell cycle which caused hyperplasia, a pathologic form of enhanced cell 
proliferation in the adult heart (Colomer et al., 2004). 
To avoid interaction of the expressed GECI with endogenous cellular processes a different 
type of calcium indicators – TnC-based calcium indicators – can be picked for the generation 
of transgenic animals. Troponin C is solely expressed in muscle tissue and in contrast to CaM 
its function is restricted to muscle contraction and does not interfere with further signaling 
processes. It has been shown before that a derivate of the TnC-based calcium indicator TN-
L15 was successfully and functionally expressed in mice without deploying any obvious 
visible cellular defects (Heim et al., 2007).  
 
 
Figure 8: Ratiometric properties of TN-XXL in neurons in vivo. Imaging of sensory evoked calcium 
transients recorded in cortical neurons of the mouse visual cortex to moving bars of different orientations 
(indicated by arrows). The upper traces display the effect of motion artifacts caused by the respiratory 
system on the single emission channel readout (ECFP, black; cpCitrine, red). The lower trace (blue) 
illustrates a distinct orientation selective response to up- and downward motion due to the reduction of 
motion artifacts by the calculation of the ratio (R) (cpCitrine/ECFP). Alexandre Ferraro Santos unpublished 
observations. 
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Its improved version TN-XXL which possesses better calcium affinity and higher dynamic 
range was already tested in in vivo experiments in the mouse visual system whereby chronic 
calcium imaging from cortical neurons over weeks also yielded reproducible orientation-
selective responses without displaying neuronal defects or changes in cell morphology 
(Mank et al., 2008). Together with the ratiometric readout which facilitates imaging of 
moving tissues (Figure 8), overcomes fluctuation of the light source or uneven expression 
levels this characterizes TnC-based calcium indicators in general and TN-XXL in particular 
as suitable candidate for long-term calcium imaging experiments and the generation of 
transgenic animals. 
 
 
2.8. Transgene Promoter Candidates to Drive TN-XXL Expression in 
Mice 
 
Already mentioned, the TnC-based GECI TN-L15 successfully showed the neuronal 
expression in transgenic mice under the control of the Thy1.2 promoter (Heim et al., 2007). 
Due to the low dynamic range and the low calcium sensitivity of TN-L15 small calcium 
transients could not be recorded. Therefore, it would be beneficial to transgenically express 
the improved GECI TN-XXL in mouse lines under the Thy1.2 promoter. First described by 
Caroni and colleagues, the Thy1.2 promoter specifically drives expression of neurons in 
cortical, hippocampal, thalamic and brainstem regions of the brain in a mosaic manner 
(Caroni, 1997). This well-studied promoter was further chosen for the expression of several 
FPs whereby high-level transgene expression was observed (Feng et al., 2000). Although, 
the Thy1.2 promoter exhibits high neuronal expression, it is known to favor expression of 
neurons in layers lying 600 – 800 µm deep in the cortex (layer 4 and 5). 
To date, using standard 2-photon microscopes in vivo calcium imaging is constrained to 
depth of 400 µm and calcium imaging of deeper situated cells is just achievable with high-
end 2-photon microscope setups, which are not commonly available, yet. Therefore a 
further approach can be elaborated by using the telencephalin (TLCN) promoter, a recently 
discovered neuronal promoter, which drives transgene expression preferably in upper 
cortical layers (layer 2/3) in depth of 150 – 300 µm (Mitsui et al., 2007). Expressing TN-XXL 
driven by the TLCN promoter would be more desirable for the use of standard 2-phonton 
microscopy techniques for the study of neuronal activity in cortical regions in vivo. 
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The advances in imaging technology and the improvements of GECIs more than proved the 
applicability of GECIs to investigate neuronal function and network dynamics. The state of 
development where GECIs are found today enables first attempts to break the barrier of 
restricting the application for GECIs to the nervous system where most studies have been 
reported so far. The ability to produce transgenic animals expressing GECIs under different 
genomic promoters can open doors for the use of GECIs in more clinical relevant fields. In a 
previous study the ubiquitously expressing chicken -actin (CAG) promoter, including an 
immediate-early cytomegalovirus enhancer and a bovine globin poly-adenylation signal, 
was used for the generation of mouse lines expressing EGFP in several tissues and cell types 
(Okabe et al., 1997). 
The global expression of a GECI such as TN-XXL with its advantages of ratiometric readout 
and interoperability in this transgenic background could enable to extend the applicability 
of calcium imaging. -actin promoter driven TN-XXL expression would allow calcium 
imaging in a vast amount of organs to study calcium signaling or dysregulations, e.g. in the 
cardiovascular, the renal and the hematopoietic system where labeling of synthetic dyes or 
transfection of GECIs are difficult to achieve. Advantages of a such a ‘ready-to-image’ mouse 
would also manifest in the ease of generation and handling of cells and tissues for the 
preparation of calcium imaging experiments since methods like dye loading, transfection or 
virus mediated transduction to express calcium dyes or indicators would be redundant. 
Furthermore, a ‘ready-to-image’ mouse could be used as model organism for the extraction 
of different types of primary cell lines or the establishment of stem cell lines that can be 
used for pharmacological screenings to investigate the effect of drugs on calcium sensitive 
mechanism. 
So far calcium imaging has become essential in neuroscience, cell biology and physiological 
research. However, in vivo studies are restricted to research regarding the nervous system 
and the potential of GECIs as tool in pharmacological studies has been underachieved.  
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2.9. Objective 
 
The generation of transgenic mice expressing GECIs under different promoters will become 
a more and more valuable tool to study calcium dynamics. Therefore, a major goal of this 
work is the characterization of transgenic mice expressing TN-XXL under different 
promoters. 
A first part of this study will concentrate on the generation and characterization of 
transgenic mouse lines which express the GECI TN-XXL in the central nervous system under 
the control of the Thy1.2 and the TLCN promoter. Furthermore, expression patterns and 
expression levels of TN-XXL will be investigated in the gained mouse models. 
A further goal of this work is the examination of the functionality and biocompatibility of 
long-term expression of TN-XXL in an already existing mouse model whereby TN-XXL is 
expressed under the β-actin promoter which drives transgene expression ubiquitously in 
various cells and organs. First, levels of TN-XXL expression in different tissues will be 
observed by fluorescence microscopy. Furthermore, the functionality of TN-XXL will be 
elaborated with calcium imaging experiments in different kinds of cultured cell types and 
tissue explants. Moreover, the biocompatibility of TN-XXL will be addressed by investigating 
the viability of TN-XXL on the cellular level. Lastly, transcriptional profiling and behavioral 
analyses should clarify global effects on gene expression and animals’ behavior of long-term 
expression of TN-XXL in this mouse model to validate the applicability. 
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3. Materials and Methods 
3.1. Molecular Biology 
3.1.1. Polymerase Chain Reaction 
 
Originally developed by Mullis the PCR technique allows the amplification of DNA via the 
utilization of thermally stable bacterial or archean polymerases such as Taq or Pfu (Mullis et 
al., 1986). The different polymerases vary in DNA amplifying speed and accuracy. In this 
study, Taq polymerase was used for high speed DNA amplifications that allowed mutations 
due to the low proof-reading capability (e.g. mouse genotyping). Herculase II Fusion, a 
fusion of an engineered Pfu variant with high affinity DNA binding domain, was used for 
reactions demanding high yield, superior reliability and short cycling times. 
 
Table 1: The reaction mix of a PCR 
 
Reagent Volume Unit 
DNA template 0.5-1 µl 200ng/µl 
primer #1 1 µl 50 µM 
primer #2 1 µl 50 µM 
Herc. II Reaction Buffer 10 µl 5x 
dNTP solution 1 µl 12.5 mM 
Herculase II fusion 0.5 µl 2 U 
DMSO if needed 5 µl  
add H20 to 50 µl 
 
Addition of DMSO to the reaction mix (Table 1) often enhances the yield of DNA obtained by 
the PCR especially when the reaction initially produces too little DNA, when added the water 
volume was reduced to the respective volume. All reagents were added on ice and the 
reaction was initialized with the 95°C incubation step (Table 2). Hot start increases 
specificity and reduces primer dimerization.  
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Table 2: The temporal order for the PCR reaction 
 
Reaction step Temp. Time 
1. Hot start 95°C 5 min 
2. Denaturation 95°C 30 s 
3. Annealing 55°C 1 min 
4. Elongation 68°C 1-2 min 
29x repetition of step 2.-4.  
5. Final elongation 68°C 5 min 
6. Final hold 15°C forever 
 
 
3.1.2. DNA Purification 
 
The Purification of DNA fragments > 100 nt was performed with the QIAquick PCR 
Purification Kit. In addition, to separate DNA fragments of different sizes (> 70 nt) on an 
agarose gel, the QIAquick Gel Extraction Kit was applied. The kits were used according to 
the manufacturer’s protocol. 
 
 
3.1.3. Restriction Digest of DNA 
 
Restriction endonucleases recognize a specific sequence of nucleotides and produce a cut in 
the DNA. The target sequence for restriction enzymes – a restriction site – mostly consists of 
a short palindromic DNA sequence that has a length of 4 – 8 bp. In cloning, restriction 
endonucleases are used to bind to their target site and cut DNA. This characteristic offers a 
molecular tool to specifically recombine DNA fragments. Both the vector backbone and the 
insert are digested with two different restriction enzymes. The restricted DNA fragments 
were used as substrates for the subsequent ligation reaction (Table 4). Restriction digest 
were also used to check for the successful insertion of a DNA fragment into the vector 
backbone (Table 3).  
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Table 3: Protocol for analytical digest to determine the successful insertion of DNA 
 
Reagent Volume Unit 
DNA template 1 - 2 μl 100-200 ng 
restriction enzyme 0.1 - 0.3 μl ~2 U 
BSA 0.2 μl 100 x 
restriction buffer 2 μl 10 x 
Add H2O to 20 µl total volume 
Incubate for 1 h at 37°C 
 
 
Table 4: Protocol for Preparative digests for subsequent cloning 
 
Reagent Volume Unit 
DNA template 2 - 10 μl 2-10 μg 
restriction enzyme 1 - 3 μl ~10 U 
BSA 0.5 μl 100 x 
restriction buffer 5 μl 10 x 
Add H2O to 50 µl total volume 
Incubate for 3 h to 16 h at 37°C. 
(depending on restriction enzyme used) 
 
 
3.1.4. Dephosphorylation of Vector DNA 
 
Dephosphorylation of a digested vector is used to avoid self-ligation of the opened vector. 
The removal of 5´-phosphate groups from DNA that is required for a successful ligation 
reaction is catalyzed by phosphatases. The Antarctic Phosphatase is the enzyme of choice 
because it can be heat-inactivated and the vector can be used for ligation without any 
further purification step (Table 5).  
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Table 5: Protocol for the dephosphorilation reaction 
 
Reagent Volume Units 
digested DNA vector 50 µl 100-200 ng 
Antarctic Phosphatase buffer 6 µl 10x 
Antarctic Phosphatase 1 µl 1U/µl 
Add H2O to a total volume of 60 µl 
Incubation at 37°C for 2 h 
 
To inhibit the dephosphorylating reaction the samples were incubated at 70°C for 10 min. 
 
 
3.1.5. Ligation of DNA Fragments 
 
DNA ligases catalyze the fusion of two DNA fragments with complementary sequences. 
Treatment of the vector backbone and the insertion fragment with the same set of 
restriction enzymes enables the directed introduction of the desired fragment into the 
vector backbone (Table 6). 
 
Table 6: Protocol for the ligation reaction 
 
Reagent Volume Unit 
vector DNA 0.5 - 1 μl 50 ng 
insert DNA 1 - 3 μl 150 - 250 ng 
T4 Ligase Buffer 1.5 μl 10 x 
T4 DNA ligase 0.75 μl (300 U) 
Add H2O to 15 µl total volume 
Incubate for 1 h to 16 h at room temperature. 
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3.1.6. Preparation of Chemically-competent E. coli 
 
For the preparation of chemically competent cells, E. coli strains (XL1 Blue, BL21 gold) cell 
were processed following a modified protocol according to Inoue (Inoue et al., 1990). In 
brief, cells were inoculated and grown over night in 4 ml LB medium at 37°C. After the first 
hour of growth tetracycline (10µg/ml) was added to the solution. The following day, the 
culture was transferred to 300 ml LB medium and grown until a OD600 of 0.5 - 0.6 was 
reached. The cell suspension was placed on ice for 20 min and followed by centrifugation at 
2500 g for 20 min (4°C). The supernatant was discarded and the pellet was resuspended in 
60-80 ml of chilled Inoue transformation buffer. After an additional centrifugation step at 
2500 g for 15 min (4°C) the cells were resuspended in 20 ml Inoue transformation buffer 
supplemented with 1.5 ml DMSO. The cell suspension incubated on ice for 10 min containing 
the chemically competent E. coli was aliquoted (50 μl) and stored at -80°C until usage. 
 
 
3.1.7. Transformation of Chemically-competent E. coli 
 
An aliquot of chemically competent cells (XL1 Blue, BL21 gold; see above) was thawed for 5 
min on ice and plasmid DNA (5 µl of a ligation reaction; 100 ng of purified vector DNA) was 
added. Cells were incubated on ice for 20 - 30 min and heat-shocked for 1 min at 42°C. After 
the heat-shock, cells were kept on ice for 2 min. For bacteria transformed with plasmids 
carrying an ampicillin resistance the bacteria were immediately plated. An additional step 
was necessary, when other antibiotics were used. To overcome the inhibition of protein 
synthesis caused by antibiotics 150 μl of LB-medium was added to the bacterial suspension 
and incubated for 1 h at 37°C without antibiotics before plating them onto LB-agar plates 
containing the respective antibiotic. 
3.1.8. Purification of Bacterial DNA 
 
Plasmid DNA expressed in bacteria was extracted and purified. Smaller amounts with a DNA 
yield of up to 10 µg from 2 ml bacterial culture were gained using the QIAprep Miniprep Kit. 
Processing was accomplished following the manufacturer’s protocol. Larger amounts and 
higher purity of DNA were achieved with the PureYield™ Plasmid Midiprep System. From 
200 ml bacterial culture up to 500 µg of DNA could be isolated. After purification DNA was 
stored at -20 °C. 
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3.2. Protein Biochemistry 
 
3.2.1. Protein Expression Using the E. coli BL21 Strain 
 
Protein expression vectors (pRSET, pET-28A) carrying the gene of interest were 
transformed with the E. coli strain BL21. A Starting culture of transformed bacteria culture 
was grown over-night at 37°C in 5 ml of LB medium containing the corresponding antibiotic 
(100 µg/ml). The day after the culture was transferred to 400 ml LB medium containing 
antibiotics (100 µg/ml) and let grow until an OD600 of 0.6 to 0.8 was reached. To induce 
expression 0.5 mM IPTG was added and the culture was incubated for 3 – 8 h at 37°C. 
Bacterial cells were harvested by centrifugation at 6000 g for 10 min (4°C).  
 
3.2.2. Purification of Recombinant Expressed Proteins 
 
A bacterial pellet was resuspended with 10 ml of protein resuspension buffer containing 1 
mM PMSF, 5 µg/ml Pepstatin and 1 µg/µl Leupeptin to inhibit protease activity. To induce 
cell lysis the cell suspension was incubated at -80°C for 10 min. After thawing, lysozyme (1 
mg) was added and incubated for 30 min on ice followed by addition of  Trition-X-100 (0.1 
%), DNAseI (5 µg/ml) and RNAse (5 µg/ml) and ultra-sonication for 20 min on ice. The 
sample was centrifuged for 30 min at 13.000 rpm, the supernatant containing the protein of 
interest was transferred to a new tube and 300 µl of Ni-NTA agarose was added. Binding of 
the N-terminal 6 x His-tag to the Ni-NTA agarose was allowed for 2 h at 4°C. The protein/Ni-
NTA agarose complex was put in a polypropylene column and washed with 20 ml protein 
resuspension buffer. After washing the protein was eluted with protein elution buffer. 
 
3.2.3. SDS Polyacrylamide Gel Electrophoresis 
 
To prepare protein lysates mouse tissues were dissected and cut in small pieces, frozen in 
liquid nitrogen and ground with a pestle and mortar. Fragments were suspended in RIPA 
buffer and homogenized on ice. Cell fragments were spun for 10 min at 20,000 rcf and 
supernatants were stored at -20C until usage. Next, the protein concentration was 
estimated using the BCA protein assay following the manufacturer´s instructions. 
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Separation of proteins was achieved by denaturing, discontinuous, one-dimensional SDS 
polyacryamide gel electrophoresis (SDS-PAGE) using pre-cast gels. 2x protein loading buffer 
was added to 10 µl cell lysate, boiled for 5 min at 100C and loaded on the gel. 
Electrophoresis was performed in protein running buffer at 100 V for stacking and at 130 V 
for resolving of proteins. Finally the gel was stained with Coomassie Brilliant Blue. 
 
 
3.2.4. Western Blot 
 
Proteins were electrophoretically transferred from polyacrylamide gels using the semi-dry 
blotting technique. The transfer was carried out at a current of 0.8 mA/cm2 for one hour at 
RT. Therefore, 6 layers Whatman paper wetted in anode buffer I, 3 layers Whatman paper 
wetted in anode buffer II, a Polyvinylidene fluoride membrane, the polyacrylamide gel and 6 
layers Whatman paper wetted in cathode buffer were stacked in the blotting chamber. After 
transfer of proteins, the membrane was blocked by incubation in PBS, 5% milk powder 
over-night at 4°C. The primary antibody was diluted in PBS, 0.1% Tween-20, 1% milk 
powder. Primary antibody incubation was done for 1 hour at RT. After four washing steps 
with PBS, 0.2% Tween-20 for 5 min, the membrane was incubated with HRP-coupled 
secondary antibody in PBS, 0.1% Tween-20, 1% milk powder for 1 hour at RT in the dark. 
The membrane was washed four times for 5 min; final washing was done in PBS. Bands 
were detected using ECL Western Blotting Substrate on an ECL hyperfilm. 
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3.3. Cellular Biology 
3.3.1. Preparation of Primary Cell Cultures 
 
For cell culture experiments 6-8 week old wild-type or homozygous transgenic mice were 
sacrificed by cervical dislocation. Murine kidney fibroblasts (MKF) were obtained from 
kidneys and smooth muscle cells (SMC) were obtained from bladder. Kidneys and bladder 
were transferred to a PBS containing dish and cut into small pieces. The pieces were 
incubated for 30 min at 37°C in DMEM containing 1% Pen/Strep and 2mg/ml collagenase II. 
The digested tissue was put into a cell culture dish containing DMEM + 10% FCS + 1% 
Pen/Strep. MKF culture was left for one week until the first change of medium and splitting. 
For SMC upon media change the following day the cells were ready to use. 
For the preparation of astrocytes cultures 2 day old pups were sacrificed. The skull was 
removed and the brain was dissected. The cortices were separated from the brain and put 
into HEPES (15 mM) buffered HBSS. The meninges were removed and the cortices were 
homogenized. Trypsin-EDTA (2mg/ml) was added and incubated for 10 min at 37°C. DMEM 
containing 10% FCS and 1% Pen/Strep was added and the sample was centrifuged. The 
pellet was resuspended and filtered through a 70µm cell strainer (BD Falcon) and plated in 
T75 flasks. The medium was changed every 2-3 days. After 10 days of incubation the flasks 
were shaken at 300 rpm for 6 hours at 37°C to separate oligodendrocytes from astrocytes. 
After changing of medium the shaking process was repeated for additional 24 hours. 
 
3.3.2. Dissection of Sinoatrial Node Explants from Adult Mice 
 
Mice of the age of 8-12 weeks were sacrificed. The abdomen was cut open, the diaphragm 
was carefully removed and the thorax was open by cutting along the lateral side of the rips. 
The heart was removed and flipped to the back and pinned in a 10 cm dish filled with 
silicon. While rinsing the heart with Tyrode Low solution the sinoatrial node (SAN) region 
was cut out along the superior vena cava and the crista terminalis (Glukhov et al., 2010). 
The dissected SAN was pinned on a custom built stage equipped with a temperature 
controlled perfusion system and rinsed with Tyrode III solution. 
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3.3.3. Preparation of Dispersed SAN Cells  
 
Instead of pinning the dissected SAN region on the stage (see 3.3.2) it was incubated for 5 
min at 35°C in Tyrode III. A mixture of Collagenase B (0.12 mg), Elastase (0.4 mg) and BSA 
(10 mg) was added to the solution and incubated for another 30 min at 35°C for digestion. 
After digestion the tissues were centrifuged at 700 g the supernatant was discarded and the 
medium was carefully resuspended in ‘Kraft-Brühe’. Centrifugation and the resuspension 
were repeated for four times to remove the residuals of the proteases. Before usage the 
dispersed SAN cells kept at 4°C for 30 min to recover. 
 
3.3.4. Preparation of E8.5 Hearts 
 
To obtain embryonic hearts of the desired age of 8.5 days vaginal plug checks were 
performed the morning after mating with a male mouse with a positive plug check signifying 
a successful mating event. The progress of pregnancy was calculated from this time point. 
After 8 more days of pregnancy mice were sacrificed by cervical dislocation (Stieber et al., 
2003). The abdomen was opened, the uterus was cut out and put in a dish containing chilled 
PBS. The embryos were removed and the hearts were dissected under a dissection 
stereomicroscope and transferred to dishes containing DMEM supplemented with 10% FCS 
and 1% PenStrep and incubated overnight at 37°C. Experiments were performed the day 
after dissection. 
 
3.3.5. Transfection of Primary Cultured Cells and Dissociated Neurons 
 
Delivering TN-XXL to primary cell cultures and dissociated Neurons was performed using 
the lipofectamine approach. For that purpose 2 μg of plasmid DNA were solved in 250 μl of 
Opti-MEM I. In parallel 10 μl of Lipofectamine 2000 were mixed with 250 μl of Opti-MEM I 
and incubated for 5 min at room temperature. The DNA- and the Lipofectamine-mix were 
combined allowed forming vesicles containing DNA and incubated for additional 20 min. 
The DNA-Lipofectamine-mix was added to cells growing in 30 mm glass bottom dishes and 
the transfection was allowed to proceed for 3 h incubating at 37°C with 5% CO2. After 3 h of 
incubation, cells were washed with 1 ml PBS and 2 ml of DMEM (10% FCS, 1% PenStrep) 
were added. Cells were allowed to recover from the treatment and to express the TN-XXL 
over-night and were ready to use the next day.  
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3.4. Histology and Immunohistochemistry 
3.4.1 Cryosections of Fixed Mouse Tissues 
 
Different tissues, the brain, heart, intestines, kidney, liver, skeletal muscle, spleen, stomach 
and a piece of the mouse tail where dissected from mice sacrificed by cervical dislocation. 
The mouse tissues were washed in PBS, incubated for 2 hours in 4% PFA solution at room 
temperature and transferred into PBS containing 30% sucrose for an overnight incubation 
at 4°C. To prepare for cryosectioning, the tissues were frozen in M-1 Embedding Matrix 
medium on dry ice and stored at -20°C until usage. The embedded tissues were mounted on 
a CM 3050 cryostat and cut into 25 μm thin sections. Subsequently, slices were mounted on 
glass slides, embedded with Roti-Mount Aqua and kept at 4°C until usage. 
 
 
3.4.2. DAPI Staining of Cryosections of Mouse Tissues 
 
Before embedding the slices in mounting medium DAPI diluted to 1:1000 in PBS was 
incubated for 10 min before the slides were cover with Roti Aqua Mount medium and a 
cover slip. 
 
 
3.4.3 Immunostaining of Sinoatrial Node Tissue 
 
Dispersed SAN cells (see 3.3.3.) stored in a tube were centrifuged and the medium was 
replaced carefully with PBS and the cells were fixed by incubation with 4% PFA solution for 
15-20 minutes at room temperature. The cell suspension was centrifuged again, PFA was 
exchanged with PBS and the cells were incubated for 20 minutes at room temperature in 
PBT after another step of centrifugation. The rat monoclonal antibody to HCN4 primary 
antibody was diluted 1:300 in PBT and the suspension gently shaken either for 1 - 4 hours at 
room temperature. To avoid background staining, the primary antibody solution was 
washed with PBS during a minimum of two hours during which the PBS was exchanged 
every 30 minutes. Afterwards, the Alexa568-conjugated goat anti-rat secondary antibody 
was diluted 1:400 in PBT and again left for either 4 hours at room temperature or overnight 
at 4°C. The washing procedure was repeated and the cell suspension was transferred to a 
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glass slide and covered with Roti Aqua Mount medium. Slides covered in mounting medium 
were kept refrigerated until imaging analysis. 
Fixed SAN explants were treated in the same way apart for the incubation times. Incubation 
for the first and secondary antibody was extended to 2-3 days at 4°C. 
 
 
3.4.4 Antibody Staining of Fixed Mouse Brain Sections 
 
Fluorescent protein expression was visualized in fixed 25 μm cryosections of PFA immersed, 
PCR-positive mouse brains. Immunostaining was done by incubating brain sections 
overnight at 4°C with polyclonal anti-GFP anti-rat antibodies diluted 1:200 in PBT buffer. 
The primary antibody solution was removed by washing the slices three times in PBT and 
PBS for 30 minutes and exchanged by Alexa568-labelled goat anti-rat secondary antibody 
diluted 1:400 in PBT and incubated again for either 4 hours at room temperature or 
overnight at 4°C. The first washing procedure was repeated and the slices were finally 
mounted on glass slides, covered with Roti Aqua Mount medium and a cover glass. 
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3.5. Imaging Experiments 
3.5.1. Imaging of Fixed Tissue Sections and Stained Tissues 
 
Immunostained or unstained frozen sections, stained dispersed single cells, and fixed tissue 
explants were imaged on a Leica TCS SP5 II laser scanning confocal microscope using direct 
cpCitrine excitation with an argon ion laser at 514 nm with an output power of 20%. 
Depending on the tissue preparation and section thickness the acousto-optic tunable filters 
(AOTF) were adjusted in a range of 5 – 30 %. The emission readout was recorded with a 
PMT set to 700 V and an emission bandwidth of 525 – 560 nm. Samples labeled with 
Alexa568 were additionally recorded with a 561nm DPSS (diode pumped solid state) laser 
at powers of 20-40 % at a PMT value of 700V and an emission bandwidth of 590 – 650 nm. 
The samples were visualized with oil immersion objectives 20x/0.7NA and 40x/1.25NA and 
an image resolution of 1024x1024 pixels.  
 
 
3.5.2. Fluorescence Recovery after Photo Bleaching (FRAP) 
 
FRAP experiments were done with cultured murine kidney fibroblasts (MKF) harvested 
from homozygous -actin TN-XXL mice (see above). An inverted epiflourescence microscope 
(DeltaVision RT) equipped with a quantifiable laser module with laser emission at 488nm to 
apply the bleaching pulse and a CCD camera for image capturing was used. CpCitrine was 
excited with light that was filtered with a 500/20 nm filter and the emission was read out 
with 535/25nm filter in front of the CCD camera. Cells were recorded with a 60x/1.4NA oil 
immersion objective at a resolution of 512x512 pixels and a binning of 2. The experimental 
procedure was accomplished by taking three images before applying the bleaching pulse to 
determine the baseline fluorescence followed by a laser pulse of 80 ms with a laser intensity 
of 50% at defined bleaching area of about 25 µm2. After the pulse images were taken at a 
rate of 220ms over a period of 8 seconds.  
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3.5.3. Concentration Determination of TN-XXL Expressing Tissue 
 
TN-XXL was purified from E.coli BL21 see 3.3.x and concentrated with Amicon Ultra-15 
(Millipore, MA, USA) to a concentration of 10 mg/ml (135µM). This stock solution was 
diluted to 1:20, 1:25, 1:40, 1:50, 1:80, 1:100 and 1:160 for experiments. 
Organs (hippocampus, cortex, kidney, heart, hind limb muscle) of 6-8 month old 
homozygous transgenic mice were cut into 400 µm thin section with a McIlwain tissue 
chopper and transferred to HBSS containing dishes until usage. 
The experiments were performed with a TCS SP5 II laser scanning confocal microscope. 
Laser light of a 514 nm argon ion laser at 17% output power and AOTF of 15% was used for 
direct cpCitrine excitation at a pinhole size of 80 µm. Images were recorded with a water 
immersion objective of 20x/0.5 NA magnification at a scan speed of 400 Hz with a 
resolution of 1024x1024 pixels. The emission bandwidth was set to 525 - 600nm with a 
PMT power of 650 V. These settings were used for all experiments. 
 
 
3.5.4. Imaging of Primary Cultured Cells 
 
Cells were grown on either Poly-L-lysine coated or untreated glass-bottom dishes. Before 
the start of the experiments the culture medium was exchanged with HBSS containing 
calcium and magnesium and the cells were left for 10 min to equilibrate. For the stimulation 
depending on the cell type either ATP or Carbachol was applied at a final concentration of 
10µM and 100µM, respectively. 
Calcium imaging was performed with a 40x objective on a Zeiss Axiovert 35M inverted 
microscope equipped with a CoolSnapHQ CCD camera. For ratio metric imaging, a 440/20 
excitation filter, a 455 dichroic long-pass mirror, and two emission filters (485/35 for CFP, 
535/25 for cpCitrine) operated with a filter wheel were used. The imaging parameters, 
including filter wheels, shutter and acquisition time is controlled by MetaFluor v4.6 
software.  
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3.5.5. Imaging of Embryonic Hearts 
 
To let the hearts recover, the experiments were done one day after dissection. For imaging 
experiments hearts were transferred into glass bottom dishes with Tyrode III (140mM NaCl, 
5.4mM KCl, 1mM MgCl2, 1.8mM CaCl2, 5mM HEPES, 5.5mM Glucose). The experiments were 
performed at 30°C using a custom made heating chamber attached to an inverted 
fluorescence microscope (iMic, Till Photonics) equipped with a build in 440/20 nm CFP 
excitation filter and a dual wavelength emission filter of 485/30nm for CFP and 535/30nm 
for cpCitrine. Split view mode allowed a presentation of the two emission channels to the 
CCD camera at the same time for simultaneous and faster imaging. Embryonic hearts were 
recorded with a 10x/0.3NA objective at imaging a frequency of 22 Hz with a CCD chip 
binning of 2. 
 
 
3.5.6. Imaging of Sinoatrial Node Explants from Adult Mouse Hearts 
 
After dissection the sinoatrial node (SAN) explant was pinned on a custom built 
temperature controlled stage and equilibrated with Tyrode III solution to 30°C. Single cell 
and line scan imaging was performed on a Leica TPS 5 SPII laser scanning confocal 
microscope using a 458 nm argon ion laser excitation at 20 % output power and AOTF level 
of 30%. To reduce shot noise generated by the PMTs the gain of the two emission channels 
was calibrated to a pixel intensity value of 0 for 50 % of an image recorded without laser 
illumination of the sample. Calcium imaging of single SAN cells was performed with a low 
magnifying 20x/0.5 NA water immersion objective at a 6x zoom which is coupled to the 
scanning speed to allow imaging at high speeds of 1400 Hz per line which resulted in 
acquisition time of 33ms (30Hz) per image consisting of 256x38 pixels or 129.7x19.3 µm 
per image. The emission was recorded with two PMTs, each collecting photons for the 
respective emission channel. The bandwidth of the CFP emission channel was set to 
wavelengths of 465 – 505nm at a PMT level of 750 V, the cpCitrine channel was adjusted to 
wavelengths of 525 – 600nm at a PMT level of 700 V. For the recording of line scans the 
same settings as for single cell imaging were used, except the scan speed was adjusted to 
400 Hz per line.  
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3.6. Transgenic Mice 
3.6.1. Preparations for the Generation of Transgenic Mouse Lines 
3.6.1.1. Subcloning of TN-XXL into the Thy1.2. Expression Vector 
 
In order to express TNXXL in transgenic mouse lines under control of the Thy1.2 expression 
cassette, I followed the protocol published by P. Caroni (Caroni, 1997). To enable cloning of 
TN-XXL into the pUC18_Thy1.2 vector two XhoI sites had to be introduced at the 5’ and 3’ 
ends and the EcoRI site at the 3’ end had to be removed from pRSETB:TN-XXL. Additionally, 
an EcoRV site was introduced between the stop codon (TAA) and the 3’ XhoI site to check for 
the right insertion direction. This was performed by PCR amplification with suitable primer 
pairs. The pRSETB:TN-XXL vector carrying the new restriction sites and the pUC18_Thy1.2 
vector were digested with XhoI. The digested pUC18_Thy1.2 was dephosphorylated and TN-
XXL was inserted, leading to the construct pUC18:Thy1.2_TN-XXL. pUC18:Thy1.2_TN-XXL 
was linearized by digestion with EcoRI and PvuI. 
 
3.6.1.2. Subcloning of TN-XXL into the TLCN3.9 Expression Vector 
 
The cloning vector pRSETB:SwaI-mKO2 vector was created carrying the right restriction 
sites for cloning genes of interest into the transgene expression vector pBstN:TLCN3.9. 
Starting at the 6xHis-Tag which was situated upstream of the multiple cloning site, the 
vector pRSETB:SwaI-mKO2 was composed like the following: pRSETB -6xHisTag_NheI-SwaI-
BamHI_mKO2_EcoRI-PacI-SwaI. The original insert mKO2 was exchanged with TN-XXL by 
restriction digest with BamHI and EcoRI. The resulting pRSETB-SwaI-TN-XXL vector and the 
pBstN:TLCN3.9 vector were digested with SwaI. The opened pBstN:TLCN3.9 vector was 
dephosphorylated and TN-XXL was inserted at the SwaI site. To linearize the 
pBstN:TLCN3.9_TN-XXL vector a restriction digest with XbaI and AscI was performed.  
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3.6.2. Purification of DNA fragments and pronucleus injection 
 
The linearized DNA samples were purified via agarose gel electrophoresis followed by 
electroelution of the DNA fragment from the agarose into a Spectra/Por dialysis tubing 
(Sambrook and Russell, 2001a). In order to further free the DNA of all contaminants, an ion 
exchange chromatography was performed using a small disposable Elutip-D Minicolumn. 
The column was first equilibrated in Low Salt DNA Purification Buffer, then the DNA 
obtained from the electroelution procedure applied to the column, washed with Low Salt 
Buffer and then eluted with High Salt DNA Purification Buffer. The purified DNA fragments 
were checked for purity by agarose gel electrophoresis and their concentration was 
adjusted with injection buffer to 100 ng/μl. 
 
3.6.3 Creation and Breeding of Transgenic mice 
 
Purified linear DNA fragments were used for injections into pronuclei of mouse oocytes by 
the DNA microinjection method (Nagy et al., 2003). All injection procedures were performed 
by the Transgenic Service facility at the MPI for Biochemistry in Martinsried, Germany. The 
mouse strain used for oocyte injections was C57BL/6N. Founder animals were screened for 
Thy1.2/CFP or TCLN/CFP gene sequences by PCR of genomic DNA obtained from tail lysates 
by the method described above, and PCR-positive founders were crossed with wild type 
mice. Breeding of the transgenic lines was continued with C57BL/6N mouse strain; all 
animals used were obtained from the MPI for Biochemistry's animal breeding facilities. 
All animal procedures used in this report were in accordance with guidelines of the 
committee on animals of the Max Planck Institute of Neurobiology and with the license of 
the Regierung von Oberbayern (Munich, Germany).  
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3.6.4. Genotyping 
 
Genomic DNA was gained from mouse tail tissue using the Proteinase K/isopropanol 
precipitate method (Sambrook and Russell, 2001b). Tail tissue samples of about 2-3 mm 
length were cut off and incubated in 250 µl Mouse Tail Lysis Buffer containing proteinase K 
over night at 55°C. The dissolved tail lysates were centrifuged at maximum speed for 6 
minutes, the supernatant transferred to fresh tubes, and chromosomal DNA precipitated by 
adding 200 µl isopropanol. After a second step of centrifugation the precipitated DNA 
formed a white pellet. The supernatant was discarded and the DNA pellet was resuspended 
in 200 µl TE Buffer and incubated for 30 min to 1 h at 50°C to remove the remains of 
isopropanol. For a complete resuspension the DNA was incubated at 4°C overnight. 
 
For the genotyping PCR reaction of genomic DNA two primer pairs was used (Table 7). The 
first primer was chosen to amplify a fraction of the transgene, binding at the end of the 
promoter region and in the conserved region of the CFP chromophore. The second primer 
pair, binding a part of the gene Interleukin 2 (IL-2) was used as internal control to verify the 
success of the PCR reaction. 
 
Table 7: Primer sequences for the genotyping of transgenic mice 
 
Primer Name Primer Sequence 
Mouse-Thy1.2-2_fwd 5’-GGA CCT TAG GCA GTG TCA C-3’ 
Mouse-TLCN3.9_fwd 5’-GCT GTC TCA TCA TTT TGG CAA AG 
Mouse-CFP-Chr_rev 5’-TGC AGC CCC CAG GTC AG-3’ 
Mouse-IL-2_fwd 5'-CTA GGC CAC AGA ATT GAA AGA TCT-3' 
Mouse-IL-2_rev 5'-GTA GGT GGA AAT TCT AGC ATC ATC C-3' 
 
 
Reaction mixture (Table 8) was prepared on ice and placed into the preheated thermal 
cycler and the PCR reaction was initiated (Table 9).  
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Table 8: PCR reaction mix for genotyping transgenic mice 
 
Reagent Volume Unit 
mouse tail DNA     1 µl 100 ng/µl 
dNTP 0.2 µl 12.5 mM 
Mouse Thy1.2-2_fwd 0.6 µl 20 µM 
or Mouse TLCN3.9_fwd 0.6 μl 20 µM 
Mouse CFP-Chr_rev 0.6 µl 20 µM 
Mouse-LI-2_fwd 0.3 µl 20 µM 
Mouse-LI-2_rev 0.3 µl 20 µM 
Taq Polymerase Buffer 1.2 μl 10x 
Taq Polymerase 0.2 μl 5 U/μl 
add H2O to a total volume of 12 µl 
 
 
Table 9: PCR protocol for genotyping transgenic mice 
 
Reaction step Temp. Time 
1. Hot start 94°C 1.5 min 
2. Denaturation 94°C 30 s 
3. Annealing 60°C 1 min 
4. Elongation 72°C 30 s 
35x repetition of step 2.-4. 
6. Final hold 10°C forever 
 
 
After the PCR reaction the whole sample was used for analysis using agarose gel 
electrophoresis.  
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3.6.5 Breeding mouse lines for homozygosis 
 
Breeding pairs of two heterozygous female and one heterozygous male were prepared. The 
offspring was tested for the TN-XXL transgene by performing PCR from genomic DNA 
obtained from mouse tail tissue (see above). Defined by Mendelain inheritance, 25 % of 
offspring should be homozygous for the transgene. To analyze this, the PCR positive 
offspring (H1) of the breeding pair was backcrossed with a C57BL/6N wild type resulting in 
the crossed generation (H2). If all H2 animals are positive for the transgene the PCR positive 
H1 animal can be considered as homozygous for TN-XXL. 
 
3.7. Microarray assays 
 
For microarray analysis samples from hippocampus, heart and skeletal muscle from hind 
limb were used from 3 homozygous and 3 wild-type littermates. The tissue was dissected 
and shock-frosted in liquid nitrogen. RNA extraction and further analyses were performed 
by MFT Services (University of Tübingen, Germany). RNA was isolated and 100ng RNA per 
sample was amplified and marked with the GeneChip WT Terminal Labeling and Controls 
Kit (Ambion). Amplified and marked the RNA was hybridized on a MoGene 1.1 ST Gene Chip 
(Affymetrix Inc., Santa Clara, CA), scanned with the GeneChip Scanner 3000 and analyzed 
with the GeneChip Command Console Software AGCC 3.0 (Affymetrix Inc., Santa Clara, CA). 
Microarray data collection was normalized with robust multichip average (RMA) (Irizarry et 
al., 2003). Moreover, transcripts were filtered for non-informative transcripts. For further 
analysis only transcripts were included which were ‘detected above background’ (DABG) in 
all three array samples for at least one tissue. 
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3.8. Data Generation 
3.8.1. Image Processing 
 
To analyze FRET-based calcium recordings the ratio (R) of images from the emission 
channels of CFP and cpCitrine and subsequently the ratio change ΔR/R was calculated using 
the following formula: 
 
  
 
 
    
  
    
        
    
                            
All recorded images and movies were analyzed using ImageJ software and implemented 
plugins. In all calcium imaging experiments a background was selected from a region where 
no calcium signal was present and subtracted from the image sequence, before further 
quantification were made. Regions of interest (ROI) were manually drawn and saved with 
the ROI Manager Plugin. The mean fluorescence intensities and ratios of ROIs were 
calculated using the ROI ratio manager plugin. In all recorded z-stack the maximum 
projection was used for assembling the individual z layers. 
 
3.8.2. Data Analyses 
 
All data points obtained from imaging processing analyses were generated in Imagej and 
transferred to OriginLabs 8.1 for further analyses and graphical illustration. 
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3.9. Materials 
3.9.1. Instruments 
 
Table 10: List of instruments 
 
Name Supplier 
Autoflow CO2 Water-Jacketed Incubator NuAire, Plymouth (USA) 
Bench Top Centrifuge 5415D Eppendorf, (Germany) 
Cary 100 Scan UV-Visible Spectrophotometer Varian, Mulgrave (Australia) 
Cary Eclipse fluorescence spectrophotometer Varian, Mulgrave (Australia) 
CCD-Camera Cool Snap HQ Roper Scientific, Tucson (USA) 
Cyrostat CM 3050 Leica, Wetzlar (Germany) 
DeltaVision RT inverted microscope Applied Precision, WA (USA) 
Dissecting Microscope Leitz, Stuttgart (Germany) 
Dyad DNA Engine Peltier Thermal Cycler MJ Research Inc., Waltham (USA) 
iMIC Digital Microscope Till Photonics, Gräfelfing (Germany) 
McIlwain tissue chopper  Mickle Lab. Engineering Comp., Gomshall 
(UK) 
Metafluor 4.6 imaging software Universal Imaging, Downingtown (USA) 
Microscope  TCS SP5 II Leica, Wetzlar (Germany) 
Polytron PT 3000 Kinematica, Luzern (Switzerland) 
Mighty Small gel chamber Hoefer, San Francisco (USA) 
Amersham Hyperfilm ECL GE Healthcare, Munich (Germany) 
Microscope Axiovert 35M  Zeiss, Oberkochen (Germany) 
Shutter Lambda 10-2 Sutter Instruments, Novato (USA) 
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3.9.2. Consumables 
 
Table 11: List of consumables 
 
Name Supplier 
Calcium Calibration Buffer Kit #1 Invitrogen, Carlsbad (USA) 
cannula Neolus 26Gx23 (NN-2623R) Terumo Medical Corp., Somerset (USA) 
Domed Cap Strips for 48 Well Plates AB-Gene, Epsom (UK) 
Eartags for mice, Monel Nr. 1005-1 Nat. Band & Tag Comp., Newport (USA) 
ECL Western Blotting Substrate Thermo Scientific Pierce, Rockford (USA) 
Elutip-D Minicolumns Schleicher & Schüll, Keene (USA) 
Falcon Tissue Culture Dishes 100 mm Becton Dickinson, Franklin Lakes (USA) 
Falcon Tissue Culture Plate, 12 Well Becton Dickinson, Franklin Lakes (USA) 
Glass Bottom Culture Dishes 35mm, 
Nr. P35G-0-14-C 
MatTek Corp., Ashland (USA) 
Novex 4-12% tris-glycine gels Invitrogen, Carlsbad (USA) 
Polypropylene Columns Qiagen, Hilden (Germany) 
PureYield™ Plasmid Midiprep System Promega, Madison (USA) 
QIAprep Miniprep Kit Qiagen, Hilden (Germany) 
QIAquick Gel Extraction Kit Qiagen, Hilden (Germany) 
QIAquick PCR Purification Kit Qiagen, Hilden (Germany) 
Roti-Mount Aqua Roth, Karlsruhe (Germany) 
Spectra/Por Dialysis Membrane, 
MWCO 3500, Nr. 132111 
Spectrum Labs Inc., Rancho Dominguez 
(USA) 
Syringe (Luer-Lok) 1ml/5ml/50ml Becton Dickinson, Franklin Lakes (USA) 
Thermo-Fast 48 Well Plates for PCR  AB-Gene, Epsom (UK) 
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3.9.3. Buffers, solutions and media 
 
Table 12: List of buffers, solutions and media 
 
Name Recipe 
Anode Buffer I 300 mM Tris, pH 10.4, 20% methanol 
Anode Buffer II 25 mM Tris, pH 10.4, 20% methanol 
BAPTA Buffer for dissociation kinetics 10 mM MOPS, pH 7.5 
50 mM KCl 
20 mM BAPTA 
Cathode Buffer 25 mM Tris, pH 9.4, 
40 mM 6-aminohexanic acid, 
20 % methanol 
DMEM/10 % FCS /1% PenStrep 500 ml DMEM 
50 ml FCS, heat-inactivated 
5 ml Penicillin-Streptomycin 
DNA Gel Loading Buffer (10 x) 100 mM Tris/HCl, pH 7.5 
10 mM EDTA 
50 % Glycerol 
1 % Orange G 
DNA Purification Buffer: High Salt 20 mM Tris/HCl, pH 7.4 
1 M NaCl 
1 mM EDTA 
DNA Purification Buffer: Low Salt 20 mM Tris/HCl, pH 7.4 
200 mM NaCl 
1 mM EDTA 
HBSS for imaging 25 mM HEPES pH 7.4 
140 mM NaCl 
5 mM KCl 
1 mM CaCl2 
1 mM MgCl2 
1 mM Glucose 
0.25% BSA 
Inoue Transformation Buffer for competent 
cells 
10 mM PIPES, pH 6.7 
250 mM KCl 
15 mM CaCl2 
55 mM MnCl2 
MATERIALS AND METHODS 
- 46 - 
 
Kraftbrühe 80 mM L-glutamic acid 
25 mM KCl 
3 mM MgCl2*6H2O 
10 mM KH2PO4 
20 mM Taurine 
0.5 mM EGTA 
10 mM HEPES 
10 mM glucose*1H2O 
pH 7.4 adjusted with 5 M KOH 
LB (Luria-Bertani) medium pH 7,0 20 g/l LB broth base in ddH20 
LB Agar LB Medium 
15 g Agar 
in 1 l ddH2O 
MOPS Buffer for fluorescence spectroscopy 10 mM MOPS, pH 7.5 
100 mM KCl 
25 µM K2EGTA 
Mouse Tail Lysis Buffer 100 mM Tris/HCl, pH 8 
250 mM NaCl 
1 mM EDTA 
0.2% SDS 
200 μg/ml Proteinase K added freshly 
Neurobasal/B27 500 ml Neurobasal medium 
10 ml B27 supplement 
PBS (10 x) 100 mM Na2HPO4, pH 7.4 
20 mM KH2PO4 
1.37 M NaCl 
27 mM KCl 
PBT (1 x) 0.05 % Triton X-100 
10 % FBS 
in 1x PBS 
Poly-L-Lysine 0.01 % (w/v) Poly-L-Lysine 
Hydrobromide in H2O 
Protein Buffer for dissociation kinetics 10 mM MOPS, pH 7.5 
50 mM KCl 
4 mM CaCl2 
2 mM MgCl2 
Protein Elution Buffer 20 mM NaPO4, pH 7.8 
300 mM NaCl 
250 mM Imidazole 
Protein Loading Buffer 2x 250mM Tris pH 6.8 
10% SDS 
10% glycerol, 
10% b-mercaptoethanol 
bromophenol 
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Protein Resuspension Buffer 20 mM NaPO4, pH 7.8 
300 mM NaCl 
10 mM Imidazole 
Protein Running Buffer 10x 250 mM Tris-base, pH 8.8 
1% SDS 
1.92 M glycine 
RIPA Buffer 50 mM Tris-HCl, pH 7.5 
150 mM NaCl 
1 mM EDTA, 
1% Triton-X 100, 
0.5% sodium deoxycholate, 
0.1% SDS 
TAE (1 x) 40 mM Tris-acetate 
1 mM EDTA 
TAE (10 x) 48.4 g Tris base 
11.4 ml glacial acetic acid 
20 ml of 0.5 M EDTA, pH 8.0 
add H2O to 1 liter 
TE (1 x) 10 mM Tris/HCl, pH 8.4 
1 mM EDTA,  
Tyrode III 140 mM NaCl 
5.4 mM KCl 
1 mM MgCl2*6H2O 
1.8 mM CaCl2*2H2O 
5 mM HEPES 
5.5 mM Glucose*1H2O 
pH 7.4 adjusted with 5 M NaOH 
Tyrode low 140 mM NaCl 
5.4 mM KCl 
0.5 mM MgCl2*6H2O 
0.2 mM CaCl2*2H2O 
1.2 mM KH2PO4 
50 mM Taurine 
5 mM HEPES 
5.5 mM glucose*1H2O 
pH 6.9 adjusted with 5 M NaOH 
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3.9.4. Chemicals 
 
Table 13: List of chemicals 
 
Name Supplier 
Agar Sigma-Aldrich, St. Louis (USA) 
Ampicillin, sodium salt  Roth, Karlsruhe (Germany) 
anti-GAPDH mouse monoclonal Sigma-Aldrich, St. Louis (USA) 
anti-GFP rabbit monoclonal Research Diagnostics Inc., Flanders (USA) 
anti-HCN4 rat monoclonal Santa Cruz Biotechnology, Santa Cruz, USA 
anti-mouse IgG horse polyclonal Cell Signaling Technology, Boston (USA) 
anti-rabbit IgG goat polyclonal Cell Signaling Technology, Boston (USA) 
BAPTA, tetrapotassium salt  Molecular Probes, Eugene (USA) 
BES  Roth, Karlsruhe (Germany) 
Bovine Serum Albumin (BSA)  Sigma-Aldrich, St. Louis (USA) 
Calcium Chloride, dihydrate  Sigma-Aldrich, St. Louis (USA) 
Carbachol Sigma-Aldrich, St. Louis (USA) 
Collagenase II Worthington, Lakewood (USA) 
DAPI Sigma-Aldrich, St. Louis (USA) 
Deoxyribonuclease Sigma-Aldrich, St. Louis (USA) 
Dispase Gibco, Grand Island (USA) 
DMEM 
w/o Sodium Pyruvate; 
w/ 4500 mg/ml Glucose; 
w/ Pyridoxine-HCl 
Invitrogen, Carlsbad (USA) 
DMEM/F12 Invitrogen, Carlsbad (USA) 
DMSO (Dimethylsulfoxide) Roth, Karlsruhe (Germany) 
EGTA (Ethylene glycol bis(beta-amino ethyl 
ether tetra-acetic acid) 
Sigma-Aldrich, St. Louis (USA) 
Fetal Bovine Serum (FBS) Gibco, Grand Island (USA) 
Glucose (D-(+)-Glucose anhydrous, min 99%) Sigma-Aldrich, St. Louis (USA) 
Glycine Merck, Darmstadt (Germany) 
HEPES free acid Sigma-Aldrich, St. Louis (USA) 
Herculase II Fusion DNA Polymerase Stratagene, La Jolla (USA) 
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Imidazole Merck, Darmstadt (Germany) 
Ionomycin, calcium salt Sigma-Aldrich, St. Louis (USA) 
Kanamycin, sulfate Roth, Karlsruhe (Germany) 
Leupeptin hydrochloride Sigma-Aldrich, St. Louis (USA) 
L-Glutamic acid Roth, Karlsruhe (Germany) 
Lipofectamine 2000 Invitrogen, Carlsbad (USA) 
Lysozyme  Sigma-Aldrich, St. Louis (USA) 
M-1 Embedding Matrix Thermo Fisher Scientific, Waltham (USA) 
Magnesium chloride hexahydrate Merck, Darmstadt (Germany) 
MES monohydrate  Sigma-Aldrich, St. Louis (USA) 
MOPS  Merck, Darmstadt (Germany) 
NeuroBasal medium  Gibco, Grand Island (USA) 
Ni-NTA Agarose  Qiagen, Hilden (Germany) 
Opti-MEM I  Invitrogen, Carlsbad (USA) 
Penicillin-Streptomycin Gibco, Grand Island (USA) 
Pepstatin A Sigma-Aldrich, St. Louis (USA) 
Phenylmethylsulfonylfluoride (PMSF) Sigma-Aldrich, St. Louis (USA) 
Poly-L-lysine hydrobromide  Sigma-Aldrich, St. Louis (USA) 
Potassium chloride  Merck, Darmstadt (Germany) 
Ribonuclease A  Sigma-Aldrich, St. Louis (USA) 
Sepharose CL6B Sigma-Aldrich, St. Louis (USA) 
Sodium bicarbonate  Sigma-Aldrich, St. Louis (USA) 
Sodium chloride  Sigma-Aldrich, St. Louis (USA) 
Sodium phosphate monobasic, anhydrous Sigma-Aldrich, St. Louis (USA) 
Sucrose  Merck, Darmstadt (Germany) 
T4-Ligase  New England Biolabs, Beverly (USA) 
Tetracycline, hydro chloride Roth, Karlsruhe (Germany) 
Triton-X-100  Sigma-Aldrich, St. Louis (USA) 
Trizma Base  Sigma-Aldrich, St. Louis (USA) 
Trypsin  Sigma-Aldrich, St. Louis (USA) 
Trypsin-EDTA  Gibco, Grand Island (USA) 
Yeast extract  Sigma-Aldrich, St. Louis (USA) 
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3.9.5. Plasmids, bacterial strains, cell-lines and mice 
 
Table 14: List of plasmid for cloning and the generation of transgenic mice 
 
Plasmid Name Supplier 
pcDNA 3.1 Invitrogen, Carlsbad (USA) 
pRSET B Invitrogen, Carlsbad (USA) 
pBstN-TLCN3.9 provided by Yoshihiro Yoshihara, RIKEN 
Brain Science Institute, Saitama, Japan  
pUC 18 Thy1.2 provided by Pico Caroni, Friedrich-Miescher-
Institute, Basel, Switzerland 
 
 
Table 15: List of bacterial strains, cell-lines and transgenic mice 
 
Strain Name Supplier 
BL21(DE3) Invitrogen, Carlsbad (USA) 
XL-1 Blue Invitrogen, Carlsbad (USA) 
HEK 293T ATCC, Manassas (USA) 
β-actin TN-XXL transgenic mouse line provided by Marsilius Mues, Max-Planck-
Inst. for Neurobiology 
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4. Results 
4.1. Transgenic Mice Expressing TN-XXL under the Thy-1.2 Promoter 
 
It is known that the Thy1.2 cassette drives expression of transgenes in the nervous system in 
either a mosaic pattern or generalized manner depending on the insertion site in the 
founder line. The onset of Thy-1.2 expression of the transgene is constitutive and detectable 
from postnatal day 6-10 (Caroni, 1997). A previous study showed the successful transgenic 
expression of the troponin C-based genetically encoded calcium indicator Cer TN-L15 in the 
FVB/N mouse strain (Heim et al., 2007). This mouse strain was chosen as oocytes of FVB 
strains are highly suited for pro-nucleus injections due to their large size and the lack of 
pigmentation. However, the FVB/N mouse strain carries the retinal degeneration 1 
mutation Pde6brd1 (phophodiesterase 6B, cGMP, rod receptor, beta polypeptide) which 
causes blindness of the animal from the early onset. Despite C57BL/6N oocytes being 
smaller and pigmented and therefore more difficult to handle the C57BL/6N mice are not 
displaying a blind phenotype, which is a very important factor as studying the visual system 
is a large and important field in neuroscience e.g. studying cortical plasticity by monocular 
deprivation (Frenkel and Bear, 2004; Mrsic-Flogel et al., 2007). Indeed the scientific value of 
the visual system cannot be overstated and calcium-based studies have already shown 
imaging experiments in the primary visual cortex V1 or further downstream compartments 
of the visual system preferably with synthetic dyes (Andermann et al., 2010; Hofer et al., 
2011; Mrsic-Flogel et al., 2007; Liu et al., 2009). 
 
4.1.1. Generation of Mice Expressing TN-XXL under the Thy1.2 Promoter 
 
The generation and purification of the construct Thy1.2:TN-XXL was performed with the 
help of Marco Mank who was further involved in the genotyping of the founder lines. 
Pronucleus injection fertilized eggs of C57BL/6N oocytes carried out by the Transgenic 
Mouse Facility of the Max-Planck Institute of Biochemistry brought 105 successfully 
fertilized oocytes serving as vital founder candidates. The founder tails were identified for 
the insertion of Thy1.2:TN-XXL by PCR using a forward primer binding the terminal region 
of the Thy1.2 cassette and a reverse primer that binds the chromophore region of CFP. The 
PCR resulted in 19 positive founders indicated by a 400 bp band determined by gel 
electrophoresis. All 19 positive founders were mated with C57BL/6N wild type. The animals 
of the resulting F1 generation were also PCR validated and additionally their brains were 
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analyzed for TN-XXL expression under a fluorescence stereomicroscope. Out of 16 PCR 
positive founder lines, 2 lines were not able to produce offspring, 5 lines displayed no 
detectable expression, 5 lines displayed very little expression and 4 lines (#7952, #7959, 
#8057 and #8103) showed high TN-XXL fluorescence in post mortem ex vivo analyzed 
brains. These 4 lines were considered for further analysis. 
In transgenic animals created by pronucleus injection transgene expression can be lost over 
the generations due the mosaic manner of insertion. For observing the stable and 
permanent insertion of TN-XXL, selected PCR positive F1 generation animals of each 
founder line were mated with C57BL/6N. The PCR positive animals of the resulting F2 
generation again were mated with C57BL/6N giving generation F3. Brains analyzed from 
the F3 generation in general showed a slight decrease of TN-XXL expression compared to 
the F1 generation. Next, to facilitate the handling with the mouse lines, to remove the 
requirement of genotyping and to eventually increase the expression of TN-XXL, 
homozygous animals were generated from all 4 high transgene expressing founder lines. 
Based on the fact that all PCR positive mice are heterozygous for TN-XXL due to constant 
breeding with C57BL/6N wild types one can achieve homozygous lines by mating PCR 
positive littermates of each line among themselves resulting in homozygous generation 
(H1). To identify potential homozygous animals the H1 positives were crossed with wild 
type C57BL/6N mice. For each breeding pair at least 20 animals of the offspring were 
checked for expression by fluorescence microscopy. PCR positive mice of the H1 generation 
from all 4 founder lines were considered the breeding of homozygous mice and were 
crossed with C57BL/6N wild type mice. In the H1 generation of the lines Thy1.2:TN-XXL 
#7952, Thy1.2:TN-XXL #7959, Thy1.2:TN-XXL #8057 and Thy1.2:TN-XXL #8103 3 of 20 (2 
female and 1 male), 4 of 24 (2 female and 2 male), 6 of 23 (2 female and 4 male) and 7 of 32 
(2 female and 5 male) mice were homozygous. 
 
4.1.2. Expression Patterns of Thy1.2 TN-XXL Mouse Lines 
 
Next the lines were analyzed for expression patterns. First ex vivo brains of 6-8 weeks old 
homozygous offspring were analyzed for global expression of TN-XXL and were imaged 
from above using a custom built screening setup. In order to compare global TN-XXL 
expression levels the acceptor fluorophore cpCitrine was directly excited with a 500/20 nm 
filter with an acquisition time of 150 ms. The emission was read out with a 535/50nm filter. 
For a better estimation of the expression levels, the fluorescence intensity of the images was 
illustrated in color code (Figure 9 A). The expression levels of the Thy1.2:TN-XXL mouse 
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lines were compared to a previously generated mouse line (Thy1.2:TN-L15) amongst which 
the line TN-L15C exhibited the highest transgene expression. This mouse line was generated 
by Nicola Heim. Therefore, the TN-L15C mouse line was recorded with equal imaging 
settings. For analysis an elliptic region of interest (ROI) was drawn over the left cortical 
hemisphere of each line (n=4) quantifying the fluorescence distribution of the mouse lines. 
 
 
 
Figure 9: Thy1. TN XXL mouse lines overview. (A) Fluorescence images of the 6 homozygous mouse lines. 
Color-coded images below each line illustrate the differences in intensity of TN-XXL expression. (B) 
Statistical analysis of the brightness measured with ROIs of the left cortical hemisphere (n=4; error bar, 
S.D.) 
 
 
The highest expression was found in the TN-L15C line, however the line Thy1.2:TN-
XXL#7952 displayed a similar level of intensity. Thy1.2:TN-XXL#7959 had a decreased 
intensity compared to #7952 but was the second brightest line analyzed. For Thy1.2:TN-
XXL#8057 the intensity differed from the two analyzed breeding pairs and therefore they 
were named #8057bright and #8057dark. #8103 displayed similar brightness compared to 
#8057bright (Figure 9 B). The least expression was found in #8057dark. Whilst it is not 
abundantly clear why these differences in expression occur one can postulate that the 
differences in expression level might be due to a different number of tandem repeat 
insertions in the mouse lines (Jasin et al., 1996; Garrick et al., 1998). 
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Figure 10 Composite image of a sagittal section of Thy1.2:TN-XXL#7952. A sagittal section of a fixed 
mouse brain showing expression of TN-XXL in the olfactory bulb, cortical, hippocampal, thalamic and 
brainstem regions. 
 
 
Furthermore, 20 µm thick sagittal cryosections of PFA fixed brains from all Thy1.2:TN-XXL 
lines were taken from different regions of the brain for fluorescence microscopy using a 
laser scanning confocal microscope. For all lines the global expression pattern was similar 
and subsequently for the line #7952 a sagittal section of a whole brain was recorded, that 
serves as an estimation of expression for all analyzed mouse lines (Figure 10). Expression 
was present in the olfactory bulb, the cortex (mainly in cortical layer 4 and 5), the CA1 and 
CA3 region of the hippocampus, and various thalamic and brainstem regions. Apart from the 
cerebellar nucleus no expression could be found in the cerebellum. Brain sections from 
homozygous adult mice of the different lines were imaged with identical settings to 
maintain comparability. Pictures of the cortex, the hippocampus region CA1, the olfactory 
bulb and the cerebellum were taken and analyzed for brightness and expression pattern. 
Imaging of the cortex was performed in the visual cortex V1 situated 2.64 mm lateral and -3 
to -5 mm of Bregma. In Figure 11 examples of fluorescence pictures of six mouse lines show 
the expression in the visual cortex and the CA1 region of the hippocampus. As expected 
from the fluorescence image recorded from whole ex vivo brains, the mouse lines showed 
different fluorescence strength. 
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Figure 11 Comparison of expression patterns of the V1 cortex of 6 transgenic mouse lines. Composite 
images of sagittal cortical sections showing the region -3 to -5 mm of Bregma (V1 cortex) at 2.64 mm 
lateral. Below the cortex the CA1 region of the hippocampus and transition to the rhinal cortex is visible 
(scale bars: 500 µm). 
 
 
Expression of TN-XXL in cortical sections was present in all lines. Especially in the cortex 
differences in the background fluorescence mainly caused by the fluorescent neuropil was 
detected. The lines #7959 and #8057bright showed the highest background fluorescence 
and therefore the lowest contrast between neuropil and cell bodies (Figure 11 C and D, 
Figure 12 C and D). A comparable level of background was observed in the lines #7952 and 
TN-L15C. Here, at least some neuronal projections from deeper situated neurons are visible 
(Figure 11 A and B, Figure 12 A and B). In the lines #8057dark and #8103 the lowest 
background level was analyzed, therefore single neuronal somata, apical dendrites of layer 4 
and 5 neurons and neurons in layer 2/3 were clearly visible (Figure 11 E and F, Figure 12 E 
and F) rendering these lines suitable candidates for functional in vivo calcium imaging 
approaches.  
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Figure 12. Enlarged images of the visual cortex V1 for six Thy1.2 mouse lines. (A) The line TN-L15C which 
expresses the GECI TN-L15 driven by the Thy1.2 promoter. (B-F) 5 different mouse line expressing TN-XXL 
under the control of the Thy1.2 promoter. All pictures display a section of the primary visual cortex V1. 
The Arrow-heads on the right illustrate the tissue depth in µm from top to bottom (scale bar, 75µm). 
 
 
Nevertheless expression in the deeper layer 4 and 5 was higher than in upper layers which 
impedes imaging in upper layers. Furthermore, fluorescence in the hippocampal formation 
was present in all lines (Figure 11). Lines #7952 and #8103 showed similar strong 
expression in the CA1 region as in the lines TN-L15C #8057bright, #8057dark and #7959 
the hippocampal expression was lower. 
In the following, the fluorescence intensity in olfactory bulb was also determined by 
cryosections. In all lines examined fluorescence was absent in the granule cell layer and 
internal plexiform layer, however all lines exhibited TN-XXL expression in the mitral cell 
layer and in glomeruli of the olfactory bulb. In contrast to the lines #7952, #8057bright, 
#8057dark which displayed only low expression, the line #7959 showed high fluorescence, 
the line #8103 displayed the highest fluorescence signal in the mitral cell layer and 
glomeruli (Figure 13 A and B). Analyzing the cerebellum the only line exhibiting 
fluorescence was the line #7959, which showed expression of TN-XXL in the purkinje cell 
layer. Here, purkinje cells and projection of dendrites into the molecular layer were clearly 
visible (Figure 13 C). 
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Figure 13: Expression pattern of lines Thy1.2:TN-XXL#7959 and #8103. (A) Fluorescence image of a 
section through the olfactory bulb of line #7959. (B) Fluorescence image of a section through the olfactory 
bulb of line #8103. (C) Fluorescence image of a section through the cerebellum of line #7959 (scale bars: 
200 µm). 
 
 
To conclude, one can assume that several lines would be suitable for functional calcium 
imaging experiments. In contrast to the other lines, the high TN-XXL expression of lines 
#8103 and #7959 in the olfactory bulb entitles them most for calcium imaging in mitral cells 
and glomeruli. Additionally, in line #7959 the high expression of TN-XXL in the cerebellum 
would enable imaging of cerebellar purkinje cells. The low fluorescence background in the 
line #8057dark showing also the lowest global expression could be a candidate for imaging 
the somas in upper cortical layers 2/3 neurons with the line #7952. In line #8103 due to the 
strong expression of deeper cortical neurons, the apical dendrites could be imaged. The 
large background fluorescence present in the lines #7959 and #8057bright might impede 
functional in vivo calcium imaging experiments in the upper cortical layer 2/3. 
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4.2. Transgenic Mice Expressing TN-XXL under the Control of the 
TLCN Promoter 
 
As illustrated above, the transgene expression driven by the Thy-1.2 promoter is very low in 
the upper cortical layers, specifically in pyramidal layer 2/3. Many in vivo 2-photon studies 
successfully showed calcium signaling experiments in cortical layer 2/3 pyramidal neurons 
e.g. in visual cortex V1 (Mrsic-Flogel et al., 2007; Mank et al., 2008) or the barrel cortex 
(Stosiek et al., 2003), which were carried out either by bolus loading of synthetic calcium 
dyes (e.g. OGB-1AM), viral injections or by utero electroporation of genetically encoded 
calcium indicators (Mank et al., 2008). With most of the available standard 2-photon 
microscopes imaging depth is restricted to 200 to 400 µm depending on laser power, 
acquisition time, excitation wavelength, brightness of the indicator and refractive index of 
the tissue producing scattering artifacts. 
Therefore, it would be advantageous to create a transgenic animal that displays high 
expression levels in the upper cortical layers. Telencephalin (TLCN) a member of the ICAM 
(intracellular adhesion molecule) protein family is expressed exclusively in the 
telencephalon of mammals (Sugino et al., 1997). A previous study showed the development 
of transgenic mice expressing GFP under the control of the TLCN promoter successfully 
labeling the upper cortical layer 2/3, the dentate gyrus and the CA3 region of the 
hippocampus and the olfactory bulb (Mitsui et al., 2007). They further tested different TLCN 
promoter lengths for expression that resulted in the identification of the TLCN3.9 promoter 
that gave the best expression and therefore was chosen for this work. 
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4.2.1. Testing the Functionality of pBstN-TLCN3.9:TN-XXL in Dissociated 
Neurons 
 
The construct pTLCN:3.9:TN-XXL was generated with the help of Marco Mank and before 
creating transgenic animals the functionality of the construct was tested in dissociated 
hippocampal neuronal cultures isolated from E18 embryonic rats. For this approach 
neurons that already have been cultured for 10-14 days were chosen due to the high level of 
spontaneous activity (O’Donovan, 1999). Neurons were transfected with pTLCN3.9:TN-XXL 
by lipofection. Expression of TN-XXL was detected 2-3 days after transfection. 
 
 
 
 
 
Figure 14: Spontaneous active cultured neurons transfected with pTLCN3.9:TN-XXL. To check whether 
the construct pTLCN3.9:TN-XXL is working correctly, the functionality of TN-XXL is tested in cultured rat 
hippocampal neurons. Two neurons with different sponataneous firing pattern are depicted. Black lines 
show ratio changes due to calcium influx. The orange and blue lines illustrate the single emission channels 
for the readout of CFP and cpCitrine fluorescence, respectively (scale bars: 25 µm). 
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Figure 14 illustrates calcium imaging experiments of two cultured neurons with different 
spontaneous firing patterns recorded with an inverted epifluorescence microscope. The 
lower left and right panel showed the signal readout of the donor (CFP, blue) and the 
acceptor (cpCitrine, orange) fluorophore which demonstrates the functional expression of 
TN-XXL. Ratio changes of up to 80 % evoked by spontaneous activity could be detected in 
neuronal culture (Figure 14, black lines). 
 
 
4.2.2. Expression Pattern of TLCN3.9 TN-XXL Mouse Lines 
 
After the functionality of TLCN3.9:TN-XXL was determined by in vitro experiments in 
neuronal culture, the vector was linearized by restriction digest with XbaI and AscI and DNA 
fragments were prepared for the injection in mouse oocytes. Pronuleus injections in 
fertilized eggs of C57BL/6N oocytes were carried out by the Transgenic Mouse Facility of 
the Max-Planck Institute of Biochemistry. 
One round of pronucleus injection delivered 19 vital founder candidates. Within the founder 
candidates PCR analysis of lysed tail tissue resulted in 4 positive founders that were mated 
with wild type C57BL/6N. All mated founders were fertile and delivered vital offspring, 
which were again approved by PCR. The PCR positive offspring were checked for the 
expression of TN-XXL. Unfortunately, comparing PCR positive with negative littermates 
determined by fluorescence imaging of dissected brains, none of the 4 lines brought 
fluorescent offspring. Increasing the acquisition time of the microscope to more than 5 
seconds yield weak fluorescence identified in one of the four lines. To exclude the possibility 
that the weak signal in the one line was a result of neuronal tissue autofluorescence 
immunohistochemistry experiments were performed. Therefore, brains were cut into 20 µm 
thick sagittal sections and antibody staining against GFP was performed. The secondary 
antibody was tagged with Alexa568, a red fluorescence marker, which does not spectrally 
interfere with cpCitrine fluorescence. Additionally, positive controls with Thy1.2:TN-
XXL#7952 and negative controls of wild type C57BL/6N were treated in an identical 
manner. 
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Figure 15: Immunostaining of various mouse lines against GFP. Left column shows the expression level of 
TN-XXL directly excited with cpCitrine. The column in the middle depicts anti-GFP staining with Alexa568 
co-staining. The right column shows the overlay of the cpCitrine and Alexa568 channel. (A) Wild type 
negative control which as expected shows no expression of TN-XXL in cortex. (B) Positive control of a 
Thy1.2:TN-XXL#7952 shows expression in cortex. Co-staining with Alexa568 shows labelling of cell bodies 
and neurites. The picture on the right illustrates the overlay of cpCitrine and Alexa568 channel. (C) Cortical 
and hippocampal section of TLCN:TN-XXL mouse line. Fluorescence signal of TN-XXL in the cpCitrine 
channel is absent due to weak expression (left). Anti-GFP counter-staining with Alexa568 shows 
expression of TN-XXL (middle) in cortical layers 2/3 and 4/5 (top) and CA1 region of hippocampus (bottom) 
(scale bars: 200 µm). 
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As expected the negative control did not show any fluorescence in the emission channels for 
cpCitrine and Alexa568 (Figure 15 A). The positive control showed high TN-XXL expression 
in cortical layer 4 and 5 that overlapped with the antibody staining against GFP illuminated 
in the Alexa568 channel (Figure 15 B). In the sections of TLCN3.9:TN-XXL brain no 
fluorescence was detectable by the direct excitation of cpCitrine caused by the low 
expression of TN-XXL in the cortical and hippocampal regions. However, expression was 
confirmed by the antibody staining against GFP visualized with Alexa568. Here, a strong 
labeling of the CA1 region of the hippocampus and upper cortical regions most probably 
layer 2/3 neuron was noticeable (Figure 15 C). 
Despite the successful integration of TLCN3.9:TN-XXL in the mouse genome, the expression 
levels were too low to be visualized by fluorescence microscopy and could solely be 
confirmed by antibody staining against TN-XXL. 
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4.3. Transgenic Mice Expressing TN-XXL under the Control of the β-
actin Promoter 
 
Previously an in vivo study showed that TN-XXL is able to resolve signals in orientation-
selective neurons in the visual cortex of mice (Mank et al., 2008). As calcium plays a role in 
many different cellular processes and functions as second messenger several kinds of 
cellular mechanisms, a mouse expressing TN-XXL ubiquitously would enable to study 
calcium transients in a large variety of tissues. 
Here, a mouse line which expresses TN-XXL under the control of the well-studied β-actin 
promoter (Okabe et al., 1997) was chosen to characterize the functionality of TN-XXL on a 
transgenic background. Additionally, a woodchuck hepatitis virus posttranscriptional 
regulatory element (WPRE) was placed downstream of TN-XXL to enhance the expression of 
the transgene (Hlavaty et al., 2005; Zufferey et al., 1999) (Figure 16 A). Marsilius Mues 
(Max-Planck Institute of Neurobiology, Department of Neuroimmunology) generated and 
provided this mouse line that was created on a C57BL/6N background. Animals from this 
mouse line exhibited normal lifespan, fertility, body and litter sizes compared to their non-
transgenic siblings. 
 
 
 
Figure 16: Construction of TN-XXL and Western blot analysis of tissues expressing TN-XXL under the 
control of the -actin promoter. (A) Scheme of the construct with the CMV immediate-early enhancer 
(CMV-IE) and chicken (chk) -actin promoter upstream and the WPRE downstream of TN-XXL. (B) Western 
blot analyses of different tissue lysates using an anti-GFP antibody for the TN-XXL expression and an anti-
GAP-DH antibody as control performed by Marsilius Mues. 
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4.3.1. Western Blot Analysis of β-actin TN-XXL mice tissues 
 
First, to elaborate whether TN-XXL is successfully expressed in different kinds of tissues, 
samples from hind limb muscle, the heart, kidney, the spleen, the liver, and different regions 
from the brain (cortex, hippocampus, cerebellum and spinal cord) of 3-4 month old 
homozygous mice were examined by western blot analysis (Figure 16 B). Together with the 
help of Marsilius Mues the tissues were homogenized, separated via gel electrophoresis and 
stained with anti-GFP and anti-GAPDH control antibodies. The anti-GFP staining showed a 
single band of different intensities at roughly 69kDa demonstrating the expression of TN-
XXL in all observed tissue samples. Upon further analysis the bands of muscle, heart, cortical 
and hippocampal tissue showed higher intensities than bands of kidney, liver, spleen 
cerebellum and spinal cord indicating higher expression level of TN-XXL in brighter bands 
compared to the constant intensity of the staining control with anti-GAPDH at 30kDa 
(Figure 16 B). 
 
4.3.2. Observing Fluorescence Expression pattern of β-actin TN-XXL mice 
 
To further analyze the expression distribution of TN-XXL in this mouse line a series of 
fluorescence images of whole animals, organs and tissue section were prepared. Images of 3 
day old homozygous, heterozygous and wild-type pups were compared demonstrating clear 
fluorescence of the animals’ skin in the transgenic pups (Figure 17 A). A higher expression 
in homozygous compared to heterozygous mice was found confirming an increase of 
expression caused by homozygosity. The fluorescence of the pups verified that the onset of 
TN-XXL expression already takes place during development. To further categorize the 
expression pattern of the transgenic animals a series of organs were isolated from 
homozygous adult mice and were compared to wild type C57BL/6N mice of similar age by 
fluorescence imaging (Figure 17 B). Going along with the western blot results the highest 
expression was examined in brain, skeletal muscle and heart. Lower expression was found 
in liver and kidney. However, in contrast to the results from western blot fluorescence in 
spleen was almost undetectable (Figure 17 B). 
To investigate if the expression derived either from a ubiquitous equal expression in all cells 
or from partial expression in subsets of cells, frozen sections of organs from homozygous 
adult mice were performed. 
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Figure 17: Fluorescence Images of pups and organs. (A) Images of 3 newborn mice (HO, homozygous; HE, 
heterozygous; WT, wild type) illuminated with bright field (monochrome), CFP (blue) and citrine (yellow) 
fluorescence. (D) Bright field and fluorescence images of isolated organs of homozygous transgenic 
compared to wild type controls (Scale bars, 2 mm). 
 
A counter staining with DAPI visualized the DNA located in the nuclei of the cells. In sagittal 
and coronal section from the brain a fluorescence distribution from high expression in 
cortex, hippocampus and cerebellum to low expression in brainstem and midbrain regions 
was detectable (Figure 18 A and B). At higher magnification an increased fluorescence in 
blood vessels compared to cells is visible (Figure 19 A, B and C). In cross sections from 
kidney the fluorescence is more prominent in the outer regions especially in subsets of 
nephrons (Figure 18 C, Figure 19 E). In sections from muscle and heart a spread in different 
types of fluorescence levels could be seen (Figure 19 D and E). Low but detectable 
punctuated fluorescence was measured in tissue from liver (Figure 19 F). In Figure 18 I a 
section through the tail showed the fluorescence in the dermis, in muscles that surround the 
bone and in blood vessels that proceed along the longitudinal axis. In sections of the spleen 
fluorescence was only present in connective tissue no expression could be detected in the 
lymph follicles of the spleen (Figure 18 G). 
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Figure 18: Overview of TN-XXL fluorescence (green) in frozen sections of several tissues counter-stained 
with DAPI (magenta). (A) Coronal brain section. (B) Sagittal brain section. (C) Kidney. (D) Skeletal muscle. 
(E) Heart. (F) Liver. (G) Spleen. (H) Intestine. (I) Section through the tail). (Scale bars, 500 µm). 
 
 
 
 
Figure 19: Fluorescence of frozen section of higher magnification. (A) Section of the hippocampus. Black 
square shows an enlargement for the region depicted on the right. (B) Section of the cortex showing weak 
labeling of cortical neurons and strong labeling of vessels. (C) Section of the cerebellum showing labeled 
neurons of the purkinje layer and vessels. (D) Section of the hind limb muscle illustrating muscle fibers of 
different expression. (E) Heart section showing a part of atrium (top) and ventricle (bottom). (F) Section 
through the liver. (G) Section of the kidney (Scale bars, 150 µm). 
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4.3.3. Indicator Concentration, Mobility and Durability Inside Cells 
4.3.3.1. Determining the TN-XXL Concentration 
 
The distribution of fluorescence in frozen sections of organs indicated differences in TN-XXL 
expression levels (Figure 18). To determine whether this observation is valid one can 
empirically determine the actual concentration by which TN-XXL is expressed and thusly 
quantify any variations in expression levels. To calculate the TN-XXL concentration in 
specific tissues, a calibration standard using TN-XXL purified from E. coli of known 
concentration (Figure 20 A) was generated and the resulting fluorescence intensities were 
compared with acute sections from skeletal muscle, heart, hippocampus, kidney and liver of 
homozygous transgenic mice. 
 
 
 
 
Figure 20: Concentration determination of TN-XXL in transgenic mice. (A) Dilution of purified TN-XXL and 
corresponding fluorescence images showing the brightness recorded with a laser scanning confocal 
microscope. (B) Calibration standard (red) of purified TN-XXL. TN-XXL dilution of 1:20, 1:25, 1:40, 1:50, 
1:80, 1:100, 1:160 from a stock solution of 10mg/ml (135 µM) imaged with 514 nm excitation and 
corresponding fluorescence emission of citrine (error bars, standard deviation; n=4). (C) Estimation of TN-
XXL protein concentration of acute slices (400 µm) from brain, kidney, liver, muscle and heart. The citrine 
fluorescence is measured and the resulting protein concentration is concluded from the calibration 
standard in D (error bars, standard deviation). 
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Therefore, a TN-XXL stock solution (135 µM) was diluted to 1:20 (6.75 µM), 1:25 (5.4 µM), 
1:40 (3.375 µM), 1:50 (2.7 µM), 1:80 (1.69 µM), 1:100 (1.35 µM) and 1:160 (0.84 µM) and 
subsequent fluorescence images were taken, from which the signal intensity was 
determined (Figure 20 B). Acute slices were imaged with the same imaging settings to 
evaluate TN-XXL concentration using the calcium insensitive directly excited acceptor 
fluorescence intensity as measure (Figure 20 C and Figure 21). To minimize tissue 
scattering artifacts z-stacks of images were taken from the first two cell layers of the sample 
(20 µm in z). The mean values of the actual measured brightness for chosen regions of 
interest (ROI) were converted to concentrations determined by the calibration standard. 
 
 
 
 
Figure 21: Expression distribution in various tissues. Fluorescence images of various acute organ slices 
(400 µm thickness) from homozygous transgenic mice and histograms illustrating the distribution of TN-
XXL expression within the given organ. A, muscle; B, heart; C, hippocampus; D, kidney; E, liver. (scale bars, 
150 µm) 
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Calculated TN-XXL concentrations were determined in hippocampal blood vessels (4.2 µM ± 
0.7), hippocampal neurons (2.3 µM ± 0.3), kidney (3.2 µM ± 1.0) and in liver (1.2 µM ± 0.2) 
(Figure 20 C). The generation of histograms helped to categorize the expression 
distribution of TN-XXL in the different tissues (Figure 21). The high standard deviation in 
kidney derived from the large variety of expression in different cell types that were not 
further identified (Figure 21 D). In muscle and heart tissue three subsets of expressing 
fibers (low, medium and high) were observed (Figure 21 A and B). In muscle tissue a 
concentration of TN-XXL from 2.4 µM to 5.7 µM and in heart tissue a similar expression 
pattern from 2.5 µM to 5.7 µM was calculated (Figure 20 C). 
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4.3.3.2. Determining TN-XXL Motility in Cells with FRAP 
 
As previous studies showed biosensors or fluorescent protein expressed in the cytosol 
might aggregate or fuse in cellular compartments. Thereby, the sensor’s mobility, diffusion 
or even signal range could be impaired. As already mentioned above, the calmodulin-based 
calcium sensor YC3.12 expressed in a transgenic mouse tended to aggregate in cortical 
neurons causing a decrease in signal strength (Hasan et al., 2004). To test for free diffusion 
and mobility of TN-XXL fluorescence recovery after photo bleaching (FRAP) experiments 
were carried out in cultured murine kidney fibroblasts (MKF) prepared from homozygous 
transgenic mice. The bleaching spot was set close to the cell membrane so that diffusion 
could have been considered only 2 dimensional (Figure 22 A, arrow). The recovery rate 
(t1/2) of 0.2 s after the bleaching pulse was comparable to rates obtained for GFP 
(Swaminathan et al., 1997) and suggested free mobility and diffusion of TN-XXL (Figure 22 
B). 
 
 
 
 
Figure 22: Fast fluorescence recovery after fluorescence recovery after photo bleaching (FRAP) 
experiments in cultured murine kidney fibroblasts (MKF) of homozygous transgenic mice. (A) 
Fluorescence images of a MKF. The images on the right show a blow-up of the region marked with a white 
rectangle in the left picture. Arrows indicate the impact of the bleaching laser pulse. The time course 
follows the recovery from the bleaching pulse (Scale bar, 15µm). (B) Graphical illustration of the bleached 
area plotted against time. Fluorescence intensities are normalized to the mean of three images taken 
before the bleaching event. The exponential fit 1st order gave a time constant (t1/2) of 0.2 s. The fast 
recovery rate indicates the distinct cytosolic expression of TN-XXL (error bars, standard deviation). 
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4.3.3.3. The Effect of Long-term TN-XXL Expression on Cellular Morphology 
 
In addition, I investigated whether long-term expression of TN-XXL could cause changes in 
cell morphology. In a previous study an aggregation of calmodulin-based calcium indicators 
in the nucleus and a resulting decrease of the calcium signal was determined in a small 
amount of cortical neurons (Tian et al., 2009). Here, I looked at 13 days, 36 days, 2 month 
and 6 month old brains from homozygous TN-XXL expressing mice and generated images of 
frozen sections of the CA1 and CA3 region of the hippocampus on a laser scanning confocal 
microscope (Figure 23 A). The cytosolic and nuclear fluorescence distribution was 
examined by drawing a line through the soma of neurons (Figure 23 B). Even though the 
expression in CA3 neurons is lower than in CA1 cells, in both regions the fluorescence is 
restricted to the cytosol (cyto) and is not visible in the nuclear region (nucl.). Statistical 
analysis revealed no significant difference in hippocampal sections of CA1 and CA3 region 
comparing the different ages (Figure 23 C). 
 
 
 
 
Figure 23: Long-term expression of TN-XXL in transgenic mice under the control of the -actin promoter. 
(A) Laser scanning confocal imaging sections through the CA1 and CA3 region of the hippocampus of P13, 
P36, 2 month and 6 month old homozygous mice (scale bar, 150 µm). (B) Fluorescence distribution 
through a cross section of the cell soma (mean value in red and standard deviation in grey). (C) Statistical 
analyses show that even expression over 6 month does not change the cytosol to nucleus ratio 
significantly (error bars, standard deviation).  
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4.3.3.4. Functionality of TN-XXL in Murine Kidney Fibroblasts (MKF) 
 
Furthermore, I tested whether long-term expression of TN-XXL would influence 
functionality and signal strength of TN-XXL. Therefore, the performance of cultured murine 
kidney fibroblasts (MKF) isolated from homozygous transgenic mice was compared to wild-
type MKF from C57BL/6N mice. Wild-type MKF were transfected overnight with 
pcDNA3.1:TN-XXL coding for cytosolic expression of TN-XXL. The culturing medium for 
calcium imaging was exchanged by HBSS and the baseline ratio (R0) was determined. To 
analyze the maximal ratio change (RCa2+) MKFs were treated with CCCP (10 µM) and 
sodium-azide NaN3 (10 µM) to inhibit cellular metabolism. Subsequently, 8 µM Ionomycin 
and 10mM extracellular CaCl2 was added to the medium and the maximal ratio change was 
determined. 
Transfected wild-type and transgenic cells displayed similar base line ratios (R0) of 
approximately 1 ± 0.1. Values obtained for RCa2+ were similar for the two expression 
conditions from 2.9 ± 0.3 and 2.7 ± 0.2 for transfected and transgenic MKFs, respectively 
(Figure 24 A). Furthermore, agonist-induced calcium responses evoked by application of 10 
µM ATP gave comparable ratio changes of ~50 % R/R in MKF of transgenic and wild-type 
mice acutely expressing TN-XXL (Figure 24 B). 
 
 
 
 
Figure 24: Functionality of TN-XXL in cultured transgenic murine kidney fibroblasts (MKF) compared to 
transfected wild type MKFs. (A) MKFs were imaged in two conditions: baseline ratio (R0; no Ca
2+
) and high 
calcium ratio (RCa2+; 10mM Ca
2+
). The ratio (YFP/CFP) of the two conditions is plotted in a histogram (WT, 
wild type MKF; TN-XXL, homozygous transgenic MKF). (B) Ratio change (R/R) of transgenic and wild type 
MKF upon application of ATP (10µM).  
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4.3.4. Calcium Responses in Primary Cells Derived from Transgenic Mice 
 
Transgenic mice stably expressing TN-XXL could be a useful source of primary cell types 
ready for various calcium imaging or drug screening applications. Therefore the 
functionality of TN-XXL was tested in three primary cell types. Smooth muscle cells from 
bladder (SMC), fibroblasts from kidney (MKF) and astrocytes from cortical tissue of 
homozygous transgenic mice were isolated and cultured (Figure 25 A). All cell types 
exhibited fluorescence for at least 8 weeks in culture (data not shown). Smooth muscle cells 
responded to application of carbachol (100 µM) with an average peak response of ~30 % 
ΔR/R and on-going calcium oscillations for several minutes (Figure 25 B, top). 
 
 
 
Figure 25: In vitro Ca
2+
 imaging of transgenically expressed TN-XXL in different cultured cell types. (A) 
Fluorescence images of aortic smooth muscle cells (SMC), murine kidney fibroblasts (MKF) and astrocytes 
(Scale bar, 25 µm). (B) The upper left graph displays the response of four SMC to carbachol (100 µM) 
treatment. The lower left graph shows the response of five murine kidney fibroblasts to ATP (10 µM). The 
four graphs on the right depict the response of astrocytes to ATP (10 µM) either with (lower two graphs) 
or without (upper two graphs) foregone spontaneous activity. 
 
RESULTS 
- 76 - 
 
Calcium responses with ratio changes of up to 60 % ΔR/R were elicited in kidney fibroblasts 
after bath application of 10 µM ATP (Figure 25 B, bottom). When 10 µM ATP was applied to 
cultured astrocytes calcium oscillations were also detected. Older, denser astrocyte culture 
showed a high rate of spontaneous oscillations. ATP increased the oscillation frequency over 
the time of application (Figure 25B, right). 
 
4.3.5. Calcium Responses of TN-XXL in Cardiac Tissues  
 
As shown before, functional TN-XXL expression in mice under the β-actin promoter was 
confirmed by calcium imaging experiments in a variety of different cultured primary cell-
types. Motion artifacts elicited by moving or contractile tissues are critical factors 
which can cause distortion of the imaging data. To overcome artifacts produced by 
tissue movements or contractions one can use ratiometric GECIs which cancel out such 
artifacts due to the ratio calculation determined from the two recorded emission 
wavelengths. 
 
 
 
Figure 26: Position of the SAN region in the mouse heart. (A) A schematic diagram of the adult mouse 
with the SAN region depicted in red. Ao, aorta; CS coronary sinus; ICV, inferior vena cava; PA, pulmonary 
artery; PV pulmonary vein; RV, right ventricle; SCV, superior vena cava. Adapted from Dobrzynski et al., 
2007. (B) Picture of the backside of the dissected heart. The SAN region is marked with black dots.  
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To determine the benefits of the ratiometric imaging readout of TN-XXL, the heart was 
chosen as it is a fast beating, highly contractile and challenging tissue for studying calcium 
transients. Hence, the following experiments were focused on a special region of the heart, 
the sinoatrial node (SAN), located posterior of the left atrium (Figure 26). The SAN is known 
to be the pacemaker region of the mammalian heart and is also cause for many heart 
diseases e.g. sinoatrial blocks or atrial arrhythmia (Monfredi et al., 2010). 
First, the correct dissection of the SAN was verified by immunostainings of dissociated SAN 
cells and SAN explants which was achieved by using antibodies against the 
hyperpolarization activated ion channel HCN4, a specific marker for pace making sinoatrial 
node cells (Liu et al., 2007)(Figure 27). 
 
 
 
 
Figure 27: Immunostainings against HCN4 channels of sinoatrial node (SAN) tissue. (A) Dissociated cells 
from a SAN preparation of transgenically expressing TN-XXL (green) and Alexa568 staining of HCN4 (red) 
show significant overlap of the lower cell (scale bar: 50 µm). (B) Immunolabeling of SAN tissue explants. 
The left image illustrates the fluorescence of TN-XXL, the image in the middle highlights the staining of 
HCN4 channels with anti-HCN4 antibody (red). On the right image the co-localization of TN-XXL and HCN4 
is clearly visible (scale bar: 500 µm). 
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4.3.5.1. Calcium Imaging in Dissociated SAN Cells and Tissue Explants 
 
Furthermore, to analyze calcium signaling in dissociated SAN cells imaging experiments 
were performed using a laser scanning confocal microscope (Figure 28 A). Imaging was 
carried out at room temperature and at an imaging frequency of 5 Hz. The calcium 
transients elicited by spontaneous contraction events in single cells were recorded. Single 
channel emissions of CFP and cpCitrine were measured and the ratio ΔR/R was calculated. 
TN-XXL was able to resolve calcium transients shown by the fluorescence intensities of CFP 
and cpCitrine and resulted in ratio changes of up to 40 % ΔR/R (Figure 28 B). Due to the low 
temperature the imaged SAN cells showed a slow contraction frequency of 40 to 80 bpm. 
Depicting ROIs at different locations of the cell illustrated an onset of the calcium wave at 
random regions (Figure 28 B). These findings could be confirmed by performing line scans 
over the horizontal axis of a cell. The onset of the calcium wave could be resolved in high 
resolution and was in a random manner (Figure 28 C). 
 
 
 
 
Figure 28: Calcium imaging of dissociated cells gained from SAN preparations. (A) Fluorescence image of 
a SAN cell (scale bar: 30 µm). (B) Calcium transients of a spontaneous active SAN cell. The emission 
channels CFP (blue) and cpCitrine (orange) and the resulting ratio changes (black) are depicted in the left 
graph. The graph on the right shows calcium response of 3 ROIs chosen in A (black, red and blue) with 
various onsets of the calcium signal. (C) Confocal line scan through the cell in A (white dotted line) 
demonstrated the onset of the calcium response in different locations (time bar: 250 ms). 
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Organ explants offer ease of pharmaceutical manipulation for research and drug screening 
applications, retain tissue context and thus are a first approximation to in vivo work. 
Consequently SAN preparations from the adult TN-XXL mouse heart were used for further 
confocal calcium imaging experiments. First, living SAN explants were analyzed on a single 
cell based resolution with an imaging frequency of 30 Hz (Figure 29 A). Keeping the 
explants at a temperature of 30°C, beating frequencies of up to 4 Hz were recorded. In 
Figure 29 B calcium imaging experiments of three cells are illustrated and ratio changes of 8 
– 16 % ΔR/R were observed depending of the preparation. Motion artifacts owing to the 
high beating frequencies were cancelled due to the ratiometric readout of TN-XXL (Figure 
29 B). 
Second, long-term studies on SAN explants were achieved. SAN explants were cultured for 
up to three days post preparation. Imaging experiments were performed on day 0 (d0), the 
day of the preparation and two days afterwards (d1, d2). Additionally, SANs were treated 
with triiodothyronine (T3) the active form of thyroid hormone. Thyroid hormone is an 
important regulator of cardiac function and its active form T3 is known to act on ion 
channels especially in the SAN which influences the heart rate (Danzi and Klein, 2004; 
Dillmann, 2002). Therefore, increasing of T3 concentrations over a longer period are 
causing tachycardia, a chronic increase of the resting heart rate. Single cells from SAN 
explants were imaged at three consecutive days (d0, d1, d2). Due to the preparation and the 
culturing in untreated SAN explants the beating frequency dropped from ~240 bpm at d0 to 
~100 bpm at d2 (Figure 29 C). Application of T3 (150nM) over three days should increase 
the heart rate (Iordanidou et al., 2010). Unfortunately, no increase in the heart rate could be 
observed between the control group and T3 treated group (Figure 29 D). 
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Figure 29: Calcium imaging of cells of an SAN explant. 30 Hz high speed imaging of three cells (blue, red, 
and black square) from three different spontaneous beating SAN explants recorded at 30°C. (A) Images 
from 3 cells of an SAN explants. (B, left) Single traces show beating rates up to 4 Hz with ΔR/R of 10-15%. 
Colors of the traces refer to the colored squares in A. (right) The single emission channels for CFP (black, 
red, navy) and cpCitrine (gray, orange, blue). (C-D) Long-term imaging of single cells in SAN explants. (C) 
Calcium signal decrease in a SAN cell imaged over three consecutive days. (D) Application of T3 (Thyroid 
hormone) over 3 days to SAN explants. 
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4.3.5.2. Calcium Imaging in the Developing Heart 
 
The heart is one of the first functional organs in developing organisms. Studying defects 
already occurring during the development of organs could help getting insight to the cure of 
further cardiovascular diseases. The β-actin promoter in this transgenic mouse line is 
switched on during fetal development; therefore, expression of TN-XXL is already present in 
this embryonic stage. Here, I managed to isolate fetal hearts at embryonic day 8.5 (E8.5) and 
performed calcium imaging experiments on the whole beating heart. 
 
 
 
 
Figure 30: Calcium imaging of a cardiac cycle in the developing heart. (A)The Ca
2+
 dependent changes in 
R/R are plotted from black (no ratio change) to white (25 % ratio change). (B) A heat map illustrating the 
progression of the calcium signal over one heart beat cycle. The color code indicates the maximal R/R at 
a given pixel and time (left). The distance the calcium wave travels over time is shown (right) (scale bar: 
150 µm). 
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For this purpose, wide-field fluorescence imaging was preferred, which allows investigating 
large scale imaging with a suitable temporal resolution. Whole E8.5 embryonic hearts were 
dissected and cultured for up to 2 days (An et al., 1996; Stieber et al., 2003). Using wide field 
calcium imaging, calcium waves travelling through the heart were recorded at a temporal 
resolution of 22 Hz and single heart beat cycles could be resolved (Figure 30 A). The 
propagation of the calcium wave across the atrial and ventricular region in roughly 300 ms 
over a distance of about 800 µm with every heart beat were determined (Figure 30 B). The 
ratiometric nature of TN-XXL facilitated imaging in this moving organ preparation and 
produced ratio changes of up to 20 % ΔR/R. The curve progression of ROIs picked in the 
atrial and ventricular region (Figure 31 A) demonstrated the temporal delay of the 
conduction of the calcium signal from the atria to the ventricles (Figure 31 B, lower graph). 
 
 
 
 
Figure 31: Signal transduction in the embryonic heart. (A) Fluorescence image of an E8.5 embryonic 
heart. Dotted circles refer to the regions of interest (ROI) shown in B (A, atrium; V, ventricle). (B) Ca
2+
 
transients of spontaneous heart beat recorded from the heart in A. The upper graphs show single traces of 
CFP (blue) and cpCitrine (orange) emission channels of ROI 1. The FRET ratio is plotted in the trace below 
(black). The lower graph shows four beating cycles for the three ROIs marked in A. The temporal delay 
from ROI 1 to ROI 3 represents the progression of the calcium wave. Note the short time delay between 
ROI1 and ROI2 within the atrial region and large delay between ROI2 and ROI3 transmission from the 
atrium to the ventricle (scale bar: 150 µm). 
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4.3.6. Transcription Profiling of TN-XXL Expression in Transgenic Mice 
 
After the functional expression of TN-XXL in transgenic mice was confirmed, genomic effects 
of TN-XXL were analyzed by genome wide transcription profiling using microarrays. 
In the past decades transcription analysis became a more and more sophisticated tool to 
investigate alteration in gene regulation. Microarrays enable studying gene knock downs 
and resulting effects on influenced signaling pathways or cascades on mRNA level as well as 
behavioral induced alterations in gene regulation. The effect of long-term expression of 
fluorescent proteins and predominantly genetically encoded biosensors in host cells or 
organisms has always been a highly discussed topic in life science since disruption of 
endogenous genes due to the integration itself cannot be excluded (Okabe et al., 1997; 
Huang et al., 2000). Furthermore, the binding unit of biosensors, in particular the calcium 
binding domains are speculated to affect endogenous calcium buffering, may interfere with 
signaling processes or modify the regulation of gene expression involved in these processes. 
Studies by which either calmodulin alone or the calmodulin-based calcium indicators were 
expressed in hearts of mice indeed caused a severe increase of the heart size due to the 
inference with endogenous signaling pathways (Colomer et al., 2004; Tallini et al., 2006). 
Here, the influence of ubiquitous expression of TN-XXL in a mouse model was observed by 
large scale transcriptional profiling of global mRNA levels in tissues where the highest level 
of TN-XXL expression was determined. Therefore, tissue samples from skeletal muscle, 
heart and hippocampus of homozygous β-actin TN-XXL mice were compared to wild type 
control mice (n = 3). The mRNAs were extracted from tissue samples, analyzed with 
Affimetrix MoGene ST1.1 arrays and processed by the company MTF Services (Tübingen, 
Germany). 
First, the data of the 18 arrays was compiled with principal component analysis (PCA) to 
display the grade of variability of a single array. A 3 dimensional scatter plot displays the 
similarity distribution of the analyzed arrays (Figure 32 A). Each data point describes one 
array.  
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Figure 32: Microarrays analysis of TN-XXL expressing mice. Gene expression in hippocampus, heart and 
skeletal muscle for homozygous transgenic (TN-XXL) and wild type control mice (WT) were compared. (A) 
3D scatter plot of a principal component analysis (PCA) illustrates the variance in gene regulation of the 
different samples. The further two points are apart, the larger the variance (XXL, transgenic; WT, wild 
type; B, hippocampus; H, heart; M, muscle). (B) Venn diagram showing the intersection of up- and down-
regulated genes of TN-XXL compared to WT of the three tissues. 
 
 
Table 16: Overview of the number of regulated genes. 
 
comparison of tissues sum of up-and 
down-regulated genes 
up-regulated 
genes 
down-regulated 
genes 
TN-XXL.muscle - WT.muscle 269 98 171 
TN-XXL.heart - WT.heart 69 38 31 
TN-XXL.hippo. - WT.hippo. 0 0 0 
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Table 17: Intersection of up-regulated genes of muscle and heart from the Venn diagram. 
 
Gene Name Fold change  Biological Function 
muscle heart 
Mt2  8.23 2.68 cellular zinc ion homeostasis; nitric oxide mediated signal transduction; 
copper ion binding 
Lrrc51  4.00 2.13 unknown 
Itgb1bp3  3.95 3.39 integrin-mediated signaling pathway; myoblast differentiation 
Coq10b  3.52 2.24 unknown 
Fbxo36  3.09 3.13 modification-dependent protein catabolic process 
Hyal3  2.42 3.09 no proved function eventually degradation of hyaluronan 
Slc10a6  2.16 2.12 sodium ion transport 
Usp2  2.13 2.03 ubiquitin-dependent protein catabolic processes 
Tef  2.10 2.67 DNA-dependent regulation of transcription 
 
 
Table 18: Intersection of down-regulated genes of muscle and heart from the Venn diagram. 
 
Gene Name Fold change  Biological Function 
muscle heart 
Adhfe1  -3.98 -2.34 oxidation of 4-hydroxybutyrate 
AI317395  -3.41 -2.72 sodium ion and carbohydrate transport 
Mlycd  -2.82 -2.26 fatty acid biosynthetic process; carboxy-lyase activity 
Ddah1  -2.63 -2.22 nitric oxide biosynthetic process; hydrolase activity; zinc ion binding 
Nfil3  -2.51 -3.70 DNA-dependent regulation of transcription 
Ypel2  -2.42 -2.32 unknown 
Mecr  -2.13 -2.10 mitochondria fatty acid biosynthetic process 
Mcat  -2.08 -2.01 mitochondria fatty acid biosynthetic process 
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Arrays which are in close proximity imply similar gene expression like it is the case for wild 
type (WT) and transgenic (XXL) probes of the hippocampus (B). A high variation was 
detected for the arrays of muscle and heart tissue, where WT arrays and XXL arrays were 
found to lay further apart (Figure 32 A). 
This preliminary approximation is additionally confirmed by the concrete number of genes 
which showed differences in regulation. A large number of genes were found showing just 
marginally altered regulation in all three tissues. To narrow down the amount of genes, 
transcript levels differences between TN-XXL and WT mice lower than 2-fold were 
considered as not relevant. Additionally, genes which are involved in circadian rhythm and 
control of molecular clocks (Dbp, Per1, Per2 and Per3 (Sakamoto and Ishida, 2000), Arntl 
(Preitner et al., 2002) and Npas2 (Hogenesch et al., 1998)) change expression and 
transcription levels on a scale of hours and were therefore excluded from the analysis. With 
a cut-off value of 2, an up-regulation of 98, 38 and 0 genes and a down-regulation of 171, 31 
and 0 genes was observed for muscle, heart and hippocampus, respectively (Table 16). 
Furthermore, a Venn diagram for the cut-off value of 2-fold illustrates an overlap of only 9 
up-regulated genes and 8 down-regulated genes in muscle and heart tissue (Figure 32 B). 
The low number of correspondence between the tissues already indicates that the 
expression of TN-XXL does not cause severe global effects to the host organism. Looking at 
these shared regulated genes also did not bring any further conclusions of the hypothesis 
that FP formation or interaction of the TN-XXL calcium binding site could administer 
cellular stress induced by production of reactive oxygen species, interference with signaling 
pathways, metabolic processes, changes in calcium homeostasis and buffering systems 
(Table 17, Table 18). 
Most notable is the significant 8.2 and 2.7 fold induction of transcripts coding for 
metallothionein-2 in muscle and heart, respectively. Metallothionein-2 is a zinc and copper 
binding protein that has been suggested to play a role in protection against oxidative 
damage (Kumari et al., 1998), but its detailed cellular role is to date unknown. One can 
speculate that the gene is induced in response to reactive oxygen species generated during 
FP chromophore formation (Tsien, 1998).  
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4.3.7. Behavioral Testing of TN-XXL Mice 
 
Behavior is the result of an array of physiological and cognitive processes that have to be 
coordinated and fine-tuned within the organism. The preceding experiments performed 
with this mouse line clearly demonstrate the functional expression of TN-XXL. In addition, 
no perturbation of the cellular morphology during long-term expression and no obvious 
effects of the transgene TN-XXL were detected since the animals exhibited normal lifespan, 
fertility, litter and body size compared to the wild-type siblings. Furthermore, the evaluation 
of gene transcription profiling showed only minor differences in gene regulation between 
transgenic and wild-type mice. To further investigate whether the cellular up- and down-
regulation of genes in response to TN-XXL expression has a global effect on the organism, a 
collaboration with the Max-Planck-Institute for Psychiatry was undertaken with the aim of 
assessing animal responses to behavioral tasks in order to evaluate the influence of TN-XXL 
expression on behavior. The experiments were carried out at the MPI for Psychiatry under 
the direction of Carsten Wotjak and were implemented by Vincenzo Micale. 
A battery of seven behavioral tasks for motor-coordination, motor-learning behavior, 
emotionality and depression-related behavior was performed and behavior of homozygous 
transgenic mice (TN-XXL) and wild-type littermates (WT) was compared. All animals (n = 
12 – 15 per group) were singly housed under an inverse 12 h light/dark cycle to ensure the 
execution of experiments during the activity phase of the animals. A detailed description of 
the experimental procedures is given in the appendix. 
Tests monitoring exploratory, motor behavior and skilled movements were performed, 
taken into consideration the pronounced expression of TN-XXL in muscle, motor neurons 
and all cortical cerebral areas. To evaluate general motor activity mice were transferred to a 
hole-board where the animals’ behavior for the covered distance, the time animals were 
moving or resting, the number of jumps, nose pokes into holes and rearing was observed for 
a period of 30 min. Animals’ movements were recorded with infrared sensors. The 
exploratory hole-board test revealed no differences between TN-XXL mice and wild type 
mice in any of the explored parameters (Figure 33 A). 
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Figure 33: Homozygous TN-XXL transgenic mice and wild-type controls (WT) were compared in a battery 
of behavioral experiments. (A) Hole board. Distance covered, distance in time, resting, jumping, rearing 
behavior and number of nose pokes were analyzed. (B) Rotarod. Mice were placed on accelerating drums. 
The time at which an animal fell from the drum was measured. Motor learning behavior was assessed by 
consecutive trials over a period of 3 days (d1, d2, d3). (C) Elevated plus maze (EPM). Time spent in open 
arm (TOA), entries in open arm (EOA) and locomotion as motility control was analyzed. (D) Social 
interaction (SI). Pairs of unfamiliar mice (n=7 pairs each) were placed into neutral environment. The time 
of active interacting contacts (sniffing, licking, close following, grooming) was recorded. (E) Acoustic startle 
response (ASR). To test for hyperarousal, startle stimuli consisted of white noise bursts of 75, 90, 105 and 
115 dB were applied. (F) Fear conditioning. Mice were placed into a shock chamber and a tone was 
presented followed by an electric foot shock. After conditioning, mice were exposed either to the tone in 
neutral environment (d1) or to the shock chamber without applying an electric shock (d2). Freezing 
behavior served as a measure of fear memory. (G) Tail-suspension test. Mice were suspended by the tail 
from a metal rod and the immobility times during the last 4 min of the 6 min trial period was recorded. 
Data provided by Carsten Wotjak and Vincenzo Micale. 
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In addition, the ‘rotarod test’ was carried out as task for motor coordination, skilled 
movement and motor learning. Animals of both groups were placed on accelerating rotating 
drums and the time until the animal fell from the drum was measured. To assess motor 
learning behavior animals received three trails per day for three consecutive days (d1, d2 
and d3). No significant differences in behavior for motor coordination (latency d1: TN-XXL: 
10.6 s ± 2.6; WT 11.8 s ± 4.0; standard deviation) and motor learning (latency d3: TN-XXL: 
23.8 s ± 6.0; WT: 20 s ± 4.8; standard deviation) could be detected (Figure 33 B). 
When exposing the test animals to tasks that are assigned to trigger anxiety like behavior 
differences became apparent. The ‘elevated plus maze’ (EPM) exploits the animal’s natural 
aversion against open spaces and conflicts with the natural instinct to explore new 
environments. Animals were placed in the center of the maze and the number of entries and 
the time spent in open and closed arms was analyzed for a period of 5 min. TN-XXL mice 
showed an increased percentage of both entries (EOA) and time (TOA) in open arms, which 
suggested a reduced anxiety-like behavior (t=2.556; p<0.05) (Figure 33 C). No difference 
was found in the total arm entries as an index of locomotion or any movement defects. 
Observing the social interaction also correlates to the level of anxiety of animals. In this task 
two animals (TN-XXL with TN-XXL, or WT with WT) were placed in a neutral environment 
and the interaction was monitored. The TN-XXL group spent more time interacting 
compared to WT (t=3.800; p<0.01) which indicates a less anxious condition of TN-XXL mice 
(Figure 33 D). Furthermore we examined the level of arousal with the startle response test. 
Acoustic bursts provoke a brainstem reflex to protect the back of the neck. Analysis showed 
a slightly higher response of TN-XXL at the noise of 105 and 115 dB (p<0.001) which 
indicates a higher degree of arousal or hyperactivity (Figure 33E). 
A further test to address induced anxiety like behavior was the ‘fear conditioning task’. In 
this test the animals were conditioned by putting them into a shock chamber applying a 
tone and an electric foot shock. The day after conditioning the animals were exposed to the 
two contexts: a neutral environment where they were solely exposed to a tone (d1) or the 
shock context without applying an electric shock (d2). This test revealed a faster decline of 
freezing in response to tone (d1) indicating an accelerated acute fear relief to the presented 
tone in TN-XXL mice (2-way ANOVA; f1: genotype, f2: intervals; p<0.001). In contrast, 
contextual conditioning (d2) showed no significant differences (Figure 33 F). Finally, TN-
XXL mice were less immobile in the tails suspension test which measures depression-like 
behavior (Figure 33G; t=2.184; p<0.05). A summary of the behavioral tasks is given by Table 
19. 
 
 
RESULTS 
- 90 - 
 
Table 19: Behavioral experiments. Summary of tasks for motor behavior, 
emotionality and depression-related behavior of transgenic mice expressing TN-
XXL compared to wild-type controls. Data provided by Carsten Wotjak and 
Vincenzo Micale. 
 
Test Behavior Phenotype 
Hole board ↔ ↔ Locomotion 
Rotarod ↔ ↔ Motor learning 
EPM ↑TOA ↑EOA ↓ Anxiety 
SI ↑ Interaction time ↓ Anxiety, ↑Social behavior 
ASR ↑ Response ↑ Arousal 
Fear condition ↓ Freezing ↓ Anxiety 
TST ↓ Immobility ↓ Depression-like phenotype 
EPM, elevated plus maze; LD, light-dark avoidance test; ASR, acoustic startle response; TOA, 
time in open arm; EOA, entries in open arm. ↓, ↑, ↔ indicating a decreased, increased or 
unchanged behavior of TN-XXL compared to WT mice, respectively. 
 
 
All in all, TN-XXL mice showed normal locomotion, motor co-ordination, spatial navigation 
and were unhindered in motor learning elaborated by the ‘hole board’ and the ‘rotarod’ 
paradigm. Furthermore, the hippocampus- and amygdala-dependent learning behavior 
determined by the ‘fear conditioning test’ remained unaffected. However, TN-XXL mice were 
less anxious and more disposed to develop active coping strategies in stressful situations. 
This implies beneficial consequences of the transgene in tests related to neuropsychiatric 
disorders. 
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5. Discussion 
 
The generation of transgenic animals expressing a genetically encoded calcium indicator 
becomes more and more important in the research field of life science. Despite the 
successful generation of transgenic animals expressing GECIs, the majority of calcium 
imaging experiments still rely on approaches based on either synthetic calcium dyes like 
OGB-1 AM, Fura-2 and Fluo-4 or on virus mediated gene transfer of GECIs. In contrast to 
transgenic approaches loading synthetic dyes or injecting GECIs in form of viruses requires 
a preceding invasive step that can cause tissue damage resulting in a corruption of the 
experimental outcome. However, several previous studies reported that transgenic long-
term expression of calmodulin-based GECIs resulted in numerous problems causing 
pathological defects of the animal or a loss of indicator function (Tallini et al., 2006; Hasan et 
al., 2004). It is thought that these effects are caused by the interference of the sensors’ 
calcium binding unit calmodulin (CaM) with endogenous CaM or further regulatory 
mechanisms. These facts have to be taken into account when the long-term expression of a 
GECI is required e.g. for the accomplishment of chronic imaging experiments. 
A more appropriate class of GECIs – troponin C-based GECIs – may be used for transgenic 
approaches as troponin C (TnC) is more biologically autonomous than CaM since it is not 
involved in further regulatory processes except muscle contraction. Preceding studies 
already reported the successful generation of transgenic mice with the TnC-based GECI TN-
L15 in the nervous system and furthermore the in utero electroporation of TN-XXL enabled 
chronic in vivo calcium 2-photon imaging in the mouse primary visual cortex V1 (Heim et al., 
2007; Mank et al., 2008). Thereby calcium transients of orientation selective cortical layer 
2/3 neurons could be recorded over days and weeks. Moreover, no morphological defects or 
loss of function caused by TN-XXL expression was reported in neither of the sensors in the 
work published. As a consequence TN-XXL was selected as the GECI of choice for this work. 
The primary aim of this thesis was the investigation and characterization of transgenic 
animals expressing the GECI TN-XXL under the control of several promoter cassettes. The 
generated transgenic mouse lines which expressed TN-XXL in the nervous system under the 
Thy1.2 and the TLCN promoter were tested for expression pattern using fluorescence 
microscopy. 
Furthermore, I performed detailed analyses of expression patterns, the functionality and the 
biocompatibility of TN-XXL expressed under the control of the ubiquitous β-actin promoter 
in an already existing mouse model. The functionality of TN-XXL was examined by in vitro 
and ex vivo experiments in a variety of cell types and in tissue explants from the developing 
and the adult heart. Moreover, the biocompatibility of long-term expression of TN-XXL was 
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determined by investigating morphological changes, elaborating genome-wide mRNA 
transcriptional analysis and finally by the exploration of behavioral experiments which 
were conducted in a collaboration with Carsten Wotjak and Vincenzo Micale from the Max-
Planck-Institute of Psychiatry. 
 
5.1. Expression of TN-XXL under the Thy1.2 Promoter 
 
The Thy1.2 promoter is a widely used and well characterized model for the generation of 
transgenic mice. It has already been used in several studies to investigate morphology of the 
brain by expressing fluorescent proteins or to study neuronal activity by expressing 
genetically encoded calcium indicators. Furthermore, the Thy1.2 expression cassette 
showed remarkable expression levels and neuron specific labeling in a sub-regional manner 
(Feng et al., 2000). 
Expression of TN-XXL under the control of the Thy1.2 promoter on a C57BL/6N background 
gave rise to a total number of 5 founder lines which displayed high expression in the central 
nervous system. Line #8057 was separated into #8057bright and #8057dark after several 
rounds of breeding due to a large difference in expression levels. Founder lines that were 
void of expression or were not able to produce offspring might have been affected by 
insertions of the transgene at sites where genomic loci responsible for fertility were 
disrupted. Analyzing the expression of TN-XXL examined by fluorescence imaging of whole 
brains brought clear differences in intensities from bright lines #7952 to dim lines such as 
#8057dark and #8103. The differences in TN-XXL expression intensity most likely derived 
from different numbers of tandem repeat insertions in the genome during the injection 
procedure (Jasin et al., 1996; Garrick et al., 1998). Surprisingly, generating homozygous 
mice did not increase the expression level which was still beneficial since no more laborious 
genotyping of the lines was necessary. Furthermore, homozygous mouse lines did not 
exhibit impairments concerning litter size, body size, fertility or conspicuous behavior. All 
examined lines displayed a similar TN-XXL expression pattern examined by fluorescence 
microscopy of fixed sagittal sections of the brain but differed in expression levels. TN-XXL 
expression was found mainly in the hippocampus, the olfactory bulb and several thalamic 
and brainstem regions. The expression explored in cortical regions was predominantly 
found in deeper cortical layers (layer 4 and 5). Additionally, all lines displayed a weaker TN-
XXL expression of neurons situated in upper cortical regions (layer 2/3). The intensity by 
which layer 2/3 neurons were detectable strongly depended on the intensity of background 
fluorescence. The background fluorescence is believed to derive from TN-XXL expression of 
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the neuropil mainly from neuronal protrusions of deeper cortical layers. The highest 
background fluorescence was observed in the lines #7959 and #8057bright whereby due to 
the high background labeling detection of cell bodies in upper cortical layers turned out to 
be difficult. Further, the line #7952 showed a moderate level of background fluorescence 
and the lines #8103 and #8057dark displayed the lowest degree of background which 
enabled the visualization of neuronal protrusions in upper cortical layers in fixed sections. 
Due to the low background fluorescence, the lines #7952, #8057dark and #8103 are 
potential candidates for the application of in vivo 2-photon imaging experiments in upper 
cortical neurons. 
In addition, the lines #7959 and #8103 displayed strong expression in the mitral cell layer 
and the glomeruli of the olfactory bulb. TN-XXL expression was absent in neurons of the 
cerebellum, except the line #7959 showed strong labeling of cell bodies and dendrites in the 
purkinje cell layer. Therefore, this mouse line could also be applicable for in vivo imaging 
experiments in purkinje cells of the cerebellum (Sullivan et al., 2005) or the investigation of 
imaging of mitral cells in the olfactory bulb (Charpak et al., 2001; Kapoor and Urban, 2006).  
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5.2. In vivo Recordings in the Visual Cortex of Thy1.2 Mice 
Expressing TN-XXL 
 
Despite the preferred Thy1.2 driven expression of TN-XXL in deeper cortical layers the line 
#7952 was taken into account for the accomplishment of in vivo calcium imaging 
experiments of neurons from the layer2/3 in the primary visual cortex V1. 
Previously it has been shown that TN-XXL expressed via virus mediated gene transfer or in 
utero electroporation is able to resolve calcium signals of direction selective neurons in the 
visual cortex V1 over days with in vivo 2-photon imaging (Mank et al., 2008). Hence, the 
suitability of the Thy1.2 TN-XXL mouse line #7952 for in vivo 2-photon calcium imaging in 
neurons of the primary visual cortex V1 was observed. To determine whether the 
expression pattern and the level of TN-XXL expression are suitable for long-term in vivo 2-
photon calcium imaging experiments Alexandre Ferraro Santos from the Max-Planck-
Institute for Neurobiology prepared and completed all in vivo imaging experiments with this 
mouse line. 
The visual system enables organisms to process visual light and construe information to 
build a representation of the surrounding environment. In general, in rodents visual 
information is transduced from sensory afferents of the retina of the eyes via the optic 
chiasm and the optic tract to project to the LGN (lateral geniculate nucleus) from where 
information is projected to the primary visual cortex V1. The primary visual cortex V1 
receives and computes spatial information mainly from the contralateral eye (Hübener, 
2003). For the investigation of long-term function and plasticity of primary visual cortical 
neurons expressing TN-XXL A. Ferraro Santos selected the monocular deprivation paradigm 
whereby one eye remains closed for a given period of time to manipulate the optical 
signaling pathway. To facilitate the experimental procedure animals were anesthetized and 
a permanent cranial window was inserted by stereotactic surgery. The cranial window was 
located at the primary visual cortex V1 to enable chronic calcium imaging without repeating 
surgical interventions. After animals recovered from the surgery they were transferred to 
the imaging setup and moving bars of different orientations were presented at random to 
inhibit stimulus adaptation. Simultaneously the calcium response of orientation selective 
neurons in layer 2/3 of the V1 cortex was recorded with a laser scanning 2-photon 
microscope.  
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Figure 34: Chronic in vivo imaging of sensory evoked calcium transients during monocular deprivation 
(MD) in the primary visual cortex V1 of the Thy1.2 TN-XXL mouse line #7952. Images on the left display 
the cortical region which was recorded before MD (control), shortly after MD (MD) and after a 2 week 
recovery phase (recovery). The panels illustrate the calcium response properties of TN-XXL to the 
presentation of moving bars of different orientations (indicated by arrows above) to the ipsilateral (left) 
and contralateral eye (right). The traces are recorded from the depicted on the left (red circle). Data from 
Alexandre Ferraro Santos (unpublished observations). 
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The stimulus was always presented to contralateral eye and additionally as a control the 
same stimulus protocol was provided to the ipsilateral eye. With the termination of the 
experiment the contralateral eye was sutured shut to inhibit visual input. During the phase 
of monocular deprivation (MD) the animals were kept under normal housing conditions. 
After one week the deprived eye was re-opened and the animals underwent the same 
stimulation protocol as in the previous experiment. This was again repeated after a two 
week recovery phase whereby the animal was kept under regular condition again. The effect 
of MD was monitored by consecutive recordings of the same neuron during a 21 day trial 
period. 
The closure of an eye elicits a disruption of information flow due to the loss of sensory input 
which in turn leads to a modification in synaptic processing and an altered computation of 
signal inputs. After a phase of recovery the orientation selectivity can be recaptured. Figure 
34 shows chronic recordings of sensory evoked calcium responses of a neuron expressing 
TN-XXL which are elicited by the presentation of moving bars in different directions. In a 
test trial before MD the neuron showed an orientation selective response with ratio changes 
of 20% to downward motion presented to the contralateral eye (Figure 34, right panel, day 
1). Furthermore, no orientation selective response was detected when the ipsilateral eye 
was stimulated (Figure 34, left panel). Recordings which were performed shortly after eye 
opening after the 7 day period of MD of the same neuron clearly demonstrate that the 
orientation selectivity disappeared (Figure 34, right panel, day 8). Moreover, the neuron 
responded to all presented stimuli in a similar manner. After a 2 week recovery phase the 
neuron regained orientation selection which is illustrated since the neuron showed the 
identical tuning to the presented stimuli than before MD (Figure 34, right panel, day 21). 
This first preliminary experiment clearly demonstrated the usefulness of transgenic mice 
expressing TN-XXL under the control of the Thy1.2 promoter. The long-term expression of 
TN-XXL enabled the recording and observation of changing response properties of single 
neurons over weeks and therefore confirmed the applicability of TN-XXL for chronic in vivo 
imaging in transgenic mice. Furthermore, this underlines the importance of the generation 
of transgenic animals expressing a GECI like TN-XXL, which will allow monitoring of single 
neurons and small neuronal networks changing their response properties during 
development, learning and memory consolidation or during the development of 
neurodegenerative diseases. 
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5.3. Transgenic Mice Expressing TN-XXL under the TLCN3.9 Promoter 
 
The functional expression of TN-XXL under the Thy1.2 promoter has been proven by chronic 
in vivo 2-photon calcium imaging experiments in the mouse visual cortex performed by A. 
Ferraro Santos. Nevertheless TN-XXL expression of neurons in upper cortical layers (layer 
2/3) was reduced by high background fluorescence. Especially the labeling of the neuropil 
which most likely derived from dendritic projections of neurons from deeper cortical layers 
disturbed the imaging quality and lowered the signal to noise ratio (SNR) which plays a role 
when imaging at faster acquisition rates is performed. To overcome the disturbing 
background fluorescence the TLCN3.9 promoter was chosen which reported to exhibit 
higher transgene expression in upper cortical neurons (Mitsui et al., 2007). 
Unfortunately, the generation of transgenic mice under the control of the TLCN3.9 did not 
reveal any founder lines that displayed expression of TN-XXL above the detection limit of 
fluorescence microscopy. However, pre-testing of the construct in neuronal culture and 
immunofluorescence labeling against TN-XXL of fixed frozen sections of brains confirmed 
the expression of TN-XXL and consequently excluded incorrect cloning of the construct or 
technical problems during the injection process. The reason why the expression of TN-XXL 
was almost absent remains unclear. Possible explanations could be very low expression of 
the TLCN promoter in general, insufficient amounts of DNA during the pronuleus injection 
procedure leading or the insertion of the TN-XXL transgene at genomic loci which already 
were silenced during development. 
Supplementary attempts to produce transgenic animals with the same construct could be 
accomplished and hopefully will result in better expression levels. Furthermore the 
insertion of the woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) 
downstream of TN-XXL could be included which is known to enhance transgene expression 
(Zufferey et al., 1999). If the TLCN3.9 promoter in general exhibit low expression levels 
other promoters with similar expression pattern must be evaluated. A recent study reported 
the generation of a toolbox of ‘Mini promoters’ with different expression in the central 
nervous system which display promising expression pattern for the study neuronal research 
(Portales-Casamar et al 2010). However, further investigations have to be accomplished to 
determine the suitability of these promoters for the generation of transgenic animals 
expressing GECIs like TN-XXL. 
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5.4. TN-XXL in Mice under the β-actin Promoter 
 
As shown before TN-XXL has proven to monitor calcium signals of neurons and neuronal 
networks. GECIs nowadays are able to compete with synthetic calcium dyes in terms of 
brightness, dynamic range and calcium affinity. In contrast to synthetic dyes GECIs have the 
advantages of labeling specificity, the ability to obtain long-term imaging and further the 
production of transgenic animals. Moreover, the importance of calcium imaging exceeds the 
central nervous system since calcium is involved in signaling processes in every cell of an 
organism and researchers would benefit from the application of GECIs in other approaches. 
To achieve this goal a transgenic mouse line was generated that globally expresses the GECI 
TN-XXL driven by the β-actin promoter. Generated by Marsilius Mues, this mouse line shows 
transgene expression in a multiple cell types and organs. In following sections the 
functionality and biocompatibility of TN-XXL is discussed. 
 
5.4.1 Ubiquitous TN-XXL Expression 
 
Initial expression analysis performed by fluorescence imaging of whole animals, organ and 
tissue section of various organs demonstrated the expression of TN-XXL in the majority of 
tissue types including brain, skeletal muscle, heart, kidney, liver and intestines. The highest 
expression levels were found in skeletal and cardiac muscle tissue which was expected 
promoted by the high endogenous expression of β-actin in these tissues. Additionally, high 
expression was found in the brain of which the highest expression was detected in blood 
vessels. Due to the cell type unspecific transgene expression of the β-actin promoter the 
identification of neurons was disturbed by glia cell fluorescence in the cortex. Nevertheless, 
regions of low glia cell density like the cerebellum or the hippocampal formation enabled 
the detection of neurons with low levels of background fluorescence. Surprisingly, no TN-
XXL expression was found in lymph follicles of the spleen and other organs of the 
hematopoietic system. Marsilius Mues performed flow cytometric and mRNA level analysis 
which showed a significant down-regulation of mRNA levels and TN-XXL expression in cells 
of hematopoietic system compared to cell derived from kidney. The mechanisms behind the 
shutdown of the transgene remain unsolved. However, it has been reported that the WPRE 
element which was integrated downstream of TN-XXL acting as expression enhancer in rare 
cases causes a down-regulation of transgenes especially in cells of the hematopoietic system 
(Werner et al., 2004). 
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Already illustrated with fluorescence microscopy the levels of TN-XXL expression clearly 
differed between tissues. By comparing fluorescence intensities from bacterial purified TN-
XXL solution with TN-XXL expressing tissues, concentrations of TN-XXL at concentrations in 
the low micromolar range (1.2 – 5.7 µM) were identified. The lowest TN-XXL expression 
analyzed was found in liver whereas as expected the highest expression levels were 
determined in skeletal muscle and cardiac tissues. Furthermore, in skeletal and cardiac 
tissue a distribution of expression into 3 cellular subsets was observed. One can speculate 
that subdivided TN-XXL expression in skeletal muscle subsidizes with the muscle type 
distribution (Type I, Type II A, type II B). This hypothesis, however, needs to be further 
investigated. The sub-division of TN-XXL expression in cardiac remains unstated. 
 
5.4.2. Long-term Expression and Performance of TN-XXL in Cultured Cells 
 
So far GECI research has focused on the improvement and extension of sensors dynamic 
range, calcium affinity, kinetics and sensor brightness that together form the fundamental 
direction for GECI development. However, the biocompatibility of GECIs played either a 
minor role or was often disregarded when engineering calcium biosensors. Nowadays, 
through the augmented complexity of experiments GECIs have become more and more 
valuable for research and the generation of transgenic animals expressing GECIs especially 
for long-term in vivo studies is essential. Therefore analyzing the biocompatibility of GECIs 
in such systems becomes of unprecedented importance. 
Previous studies already reported that the long-term expression of GECIs in some cases –
exclusively observed with CaM-based GECIs – causes punctuated aggregation, a shuttling of 
the indicator into nucleus or morphological defects (Hasan et al., 2004; Tallini et al., 2006; 
Tian et al., 2009). This is speculated to occur due to the interaction of indicator molecules 
with endogenous proteins or their interference with signaling processes which can inhibit 
indicator function and can elicit cytotoxic effect on the cell and the organism. In contrast to 
CaM-based GECIs, expression of TN-XXL did not reveal any morphological difference when 
comparing acutely transfected wild-type murine kidney fibroblasts (MKF) with MKF 
isolated from transgenic mice. Investigating the performance of TN-XXL at basal calcium 
concentrations showed indistinguishable baseline ratios which in addition demonstrated 
that endogenous calcium levels are not affected by the long-term expression of TN-XXL. 
Furthermore, examining ATP induced calcium responses in MKF between acutely and long-
term expressed TN-XXL did not reveal any differences in signal strength which indicates 
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that long-term expression does not impair the dynamic range and therefore does not alter 
TN-XXL function. 
Additionally, the functionality of transgenically expressed TN-XXL was tested in a variety of 
primary cultured cells. In MKF, smooth muscle cells (SMC) gained from bladder, cortical 
astrocytes and cardiomyocytes TN-XXL clearly followed spontaneous and agonist induced 
calcium responses. TN-XXL was able to monitor calcium transients with ratio changes up to 
60% ΔR/R in MKF. Even in astrocytes and MKF maintained in culture for up to 6 month no 
decrease or loss of TN-XXL function and only a slight reduction of expression was 
noticeable.  
Furthermore, long-term expression of TN-XXL did not show morphological changes on 
cellular and organism level. The investigation of diffusion rates in MKF of transgenically 
expressing TN-XXL with fluorescence recovery after photobleaching (FRAP) experiments 
confirmed the free-diffusible cytosolic expression of TN-XXL. In contrast to previous studies 
with CaM-based sensors (Hasan et al., 2004) neither punctuated expression due to 
aggregation nor the formation of indicator precipitates in inclusion bodies was detected in 
TN-XXL expressing MFK. Additionally, elaborated with fixed hippocampal sections in 
transgenic mice from postnatal day 13 to the age of 6 month no nuclear localization of TN-
XXL could be detected. Other than in a study where the virus mediated long-term expression 
of the CaM-based GECI G-CaMP 3 yielded a pathologic nuclear translocation and 
subsequently a reduction of indicator function determined in cortical neurons (Tian et al 
2009). 
The given results clearly demonstrate the viable and functional long-term expression of TN-
XXL. Purchasing functional primary cell cultures, mouse embryonic fibroblasts or even 
pluripotent stem cells from homozygous transgenic TN-XXL mice could be of great interest 
for research and pharmaceutical industry e.g. for the application of calcium based in vitro 
drugs screenings. 
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5.4.3. Calcium Imaging of TN-XXL in Tissues of the Developing and Adult 
Heart 
 
The functional expression of TN-XXL was already shown by the detection of calcium 
responses in various cultured cell-types. Furthermore, transgenic expression of TN-XXL 
facilitates tissue handling in rather complex experiments as no further preparations to 
enable the accomplishment of calcium imaging such as dye loading or transfection of a GECI 
were required. Apart from investigating calcium signaling in cell culture the study of tissue 
complexes and whole organs represents a superior way to gain knowledge on calcium 
dynamics as cyto-architecture tissue connectivity remains conserved. The early onset of the 
β-actin promoter moreover allowed the study of calcium signaling even in developing 
tissues. The high expression of TN-XXL in the developing heart enabled the detection of 
calcium transients spreading over the whole heart using wide-field fluorescence 
microscopy. Calcium waves initialized at the atrial region and their propagation to 
ventricles during cardiac cycles were readily recorded with TN-XXL. 
The study of calcium dynamics is not only essential during animal development but also in 
matured organisms whereby the regulation of calcium homeostasis is important to maintain 
tissue function. The rapidly beating mouse heart is probably the most challenging tissue for 
the use of GECIs. In explants of sinoatrial node (SAN), the pacemaker region of the adult 
heart, TN-XXL was able to follow calcium signals even on a single cell basis. Motion artifacts 
deriving from the fast beating SAN were cancelled out due to the ratiometric readout of TN-
XXL which simplified and assured correct signal detection and sustained robust data 
analysis. Furthermore, TN-XXL allowed tracing of calcium signals of fast beating cells in SAN 
explants whereby signals of up to 240 bpm beating frequency were readily reported. The 
transgenic expression farther permitted chronic imaging of cells in the SAN preparation 
over three consecutive days. 
The successful signal evaluation in SAN explants underlined the stable and reliable signal 
detection of TN-XXL even in tissues with fast calcium dynamics and a high degree of motion 
artifacts and favored chronic imaging due to the advantages of transgenic long-term 
expression. This striking example reveals possibilities of this mouse line to investigate 
calcium dynamics on chronic basis in other clinically relevant tissues such as kidney or liver. 
Ongoing advances in fiber-optics and endoscopic imaging techniques could further 
extrapolate the use of such a mouse line for the study of calcium homeostasis and disease 
related dysregulations in a variety of visceral organs in vivo. 
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5.4.4. Effects of TN-XXL Expression on Gene Regulation and Animal 
Behavior 
 
The effects of long-term expression of GECIs on host cells and organism have been a 
platform for discussion over a long period of time. Regardless, most efforts to improve 
GECIs were motivated by optimizing signal intensity, kinetics or dynamic range; the effects 
of chronic GECI expression usually remained disregarded and have not been studied in 
detail, yet. Analyzing the effects of TN-XXL expression on cellular level by investigating 
genomic transcription levels and on global level by studying animal behavior was necessary 
to establish a benchmark of TN-XXL biocompatibility. 
Investigating transcriptional effects of TN-XXL expression was important for two reasons. 
Firstly, global and long-term expression of TN-XXL could exhibit effects on the level of 
calcium homeostasis since cellular calcium buffering may be affected by the GECI’s calcium 
binding domain. This additional calcium buffering could elicit changes in the intrinsic 
mechanisms regulating genes coding for endogenous proteins that are involved in the 
modulation of calcium homeostasis. Secondly, during the formation of the FP fluorophore 
reactive oxygen species (ROS) are produced (Tsien, 1998) which can induce oxidative stress 
in cells. Hence both effects, the modulation of calcium buffering one the one hand and 
mechanisms coping against oxidative stress on the other should be detectable on the 
transcriptional level of genes which are involved in calcium homeostasis and oxidative 
stress prevention. 
The genome wide investigation of transcription levels of mRNAs with microarrays of tissues 
from muscle, cardiac tissue and from the hippocampal region of the brain which exhibited 
the highest expression level of TN-XXL resulted in a vast number of differently regulated 
genes. However, the majority of mRNA transcripts of genes analyzed exhibited only a mild 
up- or down-regulation which was considered insignificant (cut-off value >2-fold). Despite 
the high TN-XXL expression level in the brain, no genes were observed that exhibited a 
significantly up-/down-regulation. A reason for that might be that cerebral cells are 
unaffected by TN-XXL expression. However, TN-XXL forfeits some of its advantages in 
muscle tissue where the calcium binding domain TnC is derived from. Therefore, the main 
focus was drawn on the analysis of genes which showed significant up-or down-regulation 
in both, skeletal muscle and heart. Looking at transcription levels 9 genes were found 
showing an up-regulation and 8 a down-regulation in both, muscle and heart tissue. 
Interestingly, the transcriptional changes of the listed genes do not imply to be evidently 
TN-XXL expression related since none of them is directly involved in calcium regulation or 
cellular stress prevention. Therefore, these genes were considered physiologically 
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irrelevant. The only exception is metallothionein-2 which showed an up-regulation of 8.2 
and 2.7-fold in muscle and heart tissue, respectively. Metallothionein-2 is a zinc- and 
copper-binding protein that further is suggested to play a role in oxidative stress prevention 
by scavenging ROS, but its detailed physiological role is unknown. Although it is conceivable 
that the up-regulation is related to ROS generated during FP fluorophore formation. The 
protection against oxidative stress typically is maintained by antioxidants such as 
peroxidases, catalases or superoxide dismutases (Han et al., 2008; Stadtman, 2001) but no 
significant up-regulation of antioxidant genes was detected. A recent study, however, 
showed that exceptionally high expression of YFP, which is found in neurons of a Thy1.2-YFP 
reporter mouse line, provoked a significant up-regulation in more than 40 genes involved in 
cellular stress prevention, inflammation and apoptosis (Comley et al., 2011). Therefore, the 
long-term expression of TN-XXL is this mouse line appears to be well accepted. 
Foregoing observations regarding animals’ daily routine did not reveal any obvious effects 
of TN-XXL expression since the animals exhibited a normal life span, fertility, or mating 
behavior and showed regular litter and body sizes. Therefore, a detailed study of TN-XXL 
effects on animal behavior was performed in collaboration with Carsten Wotjak and 
Vincenzo Micale from the Max-Planck-Institute of Psychiatry. Tests covering motor 
behavior, locomotion and motor learning were selected due to the high TN-XXL expression 
in muscle and cerebral tissues. Furthermore, the animal behavior regarding anxiety and 
neuropsychiatric disorders was analyzed. No evidence for expressional effects of TN-XXL 
could be determined in tests regarding motor behavior, locomotion and motor learning 
which were covered by the ‘hole board’ and the ‘rotarod’ tasks. However, in behavioral 
experiments covering anxiety related neuropsychiatric disorders such as ‘elevated plus 
maze’, ‘fear conditioning’ and ‘social interaction’ a less anxious phenotype became apparent 
in TN-XXL mice. Furthermore, the faster fear relieve of TN-XXL mice explored in the ‘fear 
conditioning’ task indicates that these animals perform better in developing coping 
strategies to handle stressful situation. A similar phenotype was found in a recent study 
observing calcium-mediated plasticity changes in the thalamus-amygdala pathway whereby 
blocking of L-type voltage-gated calcium channels impaired the acquisition of conditioned 
fear (Langwieser et al., 2010). In this regard one can speculate that the less anxious 
phenotype is a consequence of buffering effects of TN-XXL interfering with calcium 
homeostasis which were not covered by transcriptional profiling investigations. The general 
observations of the animals’ daily routine and the detailed behavioral analysis highlighted 
that TN-XXL does not exhibit a negative effect to the animals. The unaffected motor behavior 
and the reduced anxiety and better handling of stressful situations moreover tempt to 
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speculate even beneficial effects of TN-XXL expression. These effects, however, can also be 
due to positional effects of transgene integration which have to be taken into account. 
To briefly summarize, ubiquitous TN-XXL expression exhibited only minor effects on the 
transcriptional and behavioral level which underlines the biocompatibility of TN-XXL and 
viability of this mouse model which again emphasizes the biocompatibility in contrast to 
calmodulin-based sensor studies. 
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5.5. Conclusion 
 
 
This study shows a solid foundation for the characterization of viable and functional mouse 
lines expressing the GECI TN-XXL on different transgenic backgrounds. The expression of 
TN-XXL under the Thy1.2 promoter enabled chronic in vivo imaging of sensory evoked 
calcium transients in the visual cortex despite predominant expression in deeper cortical 
layers. Using the palette of applicable promoters one could guide transgene expression to 
further desired regions. 
The main focus of this work was a detailed global analysis of function and biocompatibility 
of long-term ubiquitous TN-XXL expression in the β-actin mouse line, which to this extent 
has not been previously performed. This study establishes a fundamental experimental 
platform by which future transgenic mice expressing GECIs can be tested. Moreover, this 
work not only assesses the current features of TN-XXL expression and functionality but also 
displays important discoveries of effects that GECI expression exhibit on physiological 
systems. TN-XXL function was confirmed in various cultured cell types and in tissues 
explants of the developing and adult heart. Additionally, no defects or impairments of 
cellular function or morphology were identified in the examined TN-XXL expressing tissues 
and only minor effects were detectable in investigations on transcriptional and behavioral 
levels. Considering these minor effects the further optimization of TN-XXL, especially the 
calcium binding domain, must endeavor to assess the biocompatibility aspects of GECI 
expression at the earliest possible opportunity. A reduction of the calcium buffering capacity 
of GECIs by lowering the number of EF-hands of the sensor’s calcium binding domain is an 
approach that our group is currently undertaking. Furthermore, the implementation of new 
brighter FP variants such as mCerulean 3 (Markwardt et al., 2011) or mTurquoise (Goedhart 
et al., 2010) to substitute ECFP as a donor fluorophore, will enable imaging with lower 
intensities to reduce photo-toxic effects and lowering expression levels without losing 
imaging quality. 
As a promising tool for further investigations this ‘ready-to-image’ mouse could pioneer 
new applications in research by the facilitated harvesting and handling of cells for 
pharmaceutical drug screenings and the usage of motion retaining tissues for chronic 
calcium imaging approaches supported by the ratiometric TN-XXL imaging readout. 
Moreover, the crossing of the TN-XXL mouse line with available disease models can open a 
significant avenue of in vitro and in vivo research for the investigation of diseases exhibiting 
aberrant calcium functions. 
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Appendix 
 
Behavioral Experiments of β-actin TN-XXL Mice 
To investigate a phenotype of β-actin TN-XXL mice assessed by several behavioral task 
regarding motor behavior, emotionality and depression-related behavior a collaboration 
was established with Carsten Wotjak and Vicenzo Micale from the Max-Planck-Institute of 
Psychiatry who planned and performed all behavioral experiments. Homozygous transgenic 
β-actin TN-XXL (TG) mice and wild-type (WT) control litter mates (n = 12-15 per group) 
were transported to their new facility at the MPI of Psychiatry and were allowed to 
acclimatize to the new environment. Animals were singularly housed with food and water 
ad libidum under an inverse 12 hour light/dark cycle to enable performing the experimental 
tasks during the activity phase of the mice between 9:30 a.m. and 5 p.m. All behavioral 
experiments were carried out by Vincenzo Micale. 
 
 
Hole Board Task 
To assess general motor activity, TG and WT mice were tested in an hole-board (40×40cm) 
contained 16 equidistant holes (5.5 cm apart, 2.5cm diameter, 3 cm depth) placed in the 
central zone of the apparatus equipped with infrared beams (TrueScan; Coulbourn 
Instruments, Allentown, PA) at 300 lux for 30 min. Three infrared sensor rings (sensor 
spacing, 1.52 cm) around the boxes allowed the measurement of horizontal and vertical (up 
or down) activity. All sensor rings were connected via interface to a computer equipped 
with TruScan Software Version 99 (Coulbourn Instruments). Boxes and sensor rings were 
surrounded by an additional box made of opaque Plexiglas side walls (47 x 47 x 38 cm) 
without roof and floor. Horizontal locomotion (total distance moved), vertical movements 
(exploratory rearing), and time spent at rest, frequency of head dipping (the mouse 
introduced its nose in a hole) were analyzed during the 30 min monitoring period. After 
each session, the apparatus was cleaned with a solution containing neutral soap. 
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Rotarod Test 
The rotarod test, using an accelerating rotarod, was performed by placing mice on rotating 
drums (3 cm diameter), which is accelerated from 4 to 20 rpm over the course of 5 min. The 
time at which each animal fell from the drum was recorded automatically when it contacted 
a plate which stopped the timer. Each animal received three consecutive trials for three 
consecutive days. Data of the three trials per day were averaged to obtain a single score. 
 
 
Elevated Plus Maze (EPM) 
The apparatus consisted of two opposite open arms, (30 x 5 cm) and two arms with walls 
(30 x 5 x 14 cm) that were attached to a central platform (5 x 5 cm) to form a cross. The 
maze was elevated 50 cm from the floor (Pellow et al., 1985). Illumination measured at the 
center of the maze was 300 lux. The animal was placed at the center of the maze with its 
nose in the direction of one of the closed arms, and observed for 5 min, according to the 
following parameters: number of entries in the open and closed arms, and time of 
permanence in each of them (i.e., the time spent by the animal in the open and closed arms). 
An entry was defined as all four paws having crossed the line between an arm and the 
central area. It is accepted that the anxiolytic effect of a drug treatment is illustrated by 
increased parameters in open arms (time and/or number of entries). The augmented 
percentage of entries in open arms over the total number of entries in both arms is a good 
indicator of anxiolytic-like behavior as well, although entries in closed arms and total 
entries reflect the motor component of the exploratory activity. On removal of each mouse, 
the maze floor was carefully wiped with a wet towel. The behavior of all animals was 
recorded on a tape using a video-camera and then scored in monitor display by an 
experienced observer by means of a video/computer system. 
 
 
Tail Suspension Test 
Mice were individually suspended by the tail from a metal rod (35 cm above the floor) using 
adhesive tape. Mice demonstrated several escape-oriented behaviors interspersed with 
temporally increasing bouts of immobility. The duration of immobility was recorded during 
the last 4-min of the 6-min testing period, after a 2-min habituation period from videotapes.  
  
APPENDIX 
 
- 109 - 
 
Fear Conditioning Test 
The setup has been described and displayed in detail before (Kamprath and Wotjak, 2004). 
Briefly, the experiments were performed in two contexts: (1) the neutral test context which 
was cylindrically shaped and made of transparent Plexiglas with wood shavings as bedding 
and (2) the shock context was a cubic-shaped box with a metal grid for shock application. All 
two contexts were cleaned thoroughly after each trial with differently smelling detergents, 
and bedding was changed. For conditioning (d0), mice were placed into the shock chamber. 
After 180 s a tone was presented (9kHz, 80dB, 20s) which co-terminated with a single 
scrambled electric foot shock (2 s, 0.7 mA). Animals remained in the shock chamber for 
another 60s before they were returned to their home cages. On day 1 and day 2 after 
conditioning, mice were exposed either to the tone (200s) in the neutral test context (d1) or 
to the conditioning context (180s). The behavioral performance was videotaped by small 
CCD cameras (Conrad Electronics, Hirschau, Germany). Animals' behavior was rated off-line 
by a trained observer who was blind to the experimental condition (EVENTLOG, Robert 
Henderson, 1986). Freezing behavior was defined as immobility except for respiration 
movements and served as a measure of fear memory. 
 
 
Social Interaction Test 
Experiments were performed in a novel environment (new cage) at 300 lux that was placed 
into a soundproof isolation cubicle. The lid of the new cage was removed and the walls 
elongated by 12.5 cm of semi-transparent plastic. Pairs of unfamiliar mice (n=7 pairs of TG 
or WT) were placed into the cage per 5 min. The time spent in social interaction (active 
contact such as sniffing, licking, close following, grooming) was recorded for each pair of 
mice. 
 
 
Startle Response 
To test for hyper arousal, acoustic startle responses were measured in the following way: 
mice were placed into one out of seven identical startle set-ups, consisting of a non-
restrictive Plexiglas cylinder (inner diameter 4 cm, length 8 cm) mounted onto a plastic 
platform, each housed in a sound attenuated chamber (SRLAB, San Diego Instruments SDI, 
San Diego, CA, USA). The cylinder movement was detected by a piezoelectric element 
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mounted under each platform and the voltage output of the piezo was amplified and then 
digitized (sampling rate 1 kHz) by a computer interface (I/O-board provided by SDI). The 
startle amplitude was defined as the peak voltage output within the first 50 ms after 
stimulus onset and quantified by means of SRLAB software. Before startle measurements, 
we calibrated response sensitivities for each chamber in order to assure identical output 
levels. Startle stimuli and background noise were delivered through a high-frequency 
speaker placed 20 cm above each cage. The 3 different startle stimuli consisted of white 
noise bursts of 20 ms duration and 75, 90, 105 and 115 dB(A), respectively, and were 
presented in a constant background noise of 50 dB(A) provided by the fan. Noise intensity 
was measured using an audiometer (Radio Shack, 33-2055, RadioShack, Fort Worth, TX, 
USA). On control trials only background noise was present. After an acclimation period of 5 
min duration, 10 control trials and 20 startle stimuli of each intensity were presented in 
pseudorandom order in each test session. The interstimulus interval was 15 s averaged (13-
17 s, pseudo randomized). The startle set-ups were localized in a different building and 
startle measurements were performed by a scientist unfamiliar to the animals in order to 
avoid context reminders, thus minimizing confounding influences by context generalization. 
Plexiglas cylinders were cleaned thoroughly soap water after each trial. 
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